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Calcium transfer during acetate (A) and bicarbonate (B) hemodialysis:
U. Binswanger, Technische assistenz: C. Cajet, E. Huber, H. Kubista,
Nephrologische Station, Departement fur Innere Medizin,
Universitatsspital, 8091 Zurich, Switzerland. Dialysate buffer decrease
ionized calcium (Cat by complex formation. The present workwas
initiated to evaluate differences of A and 13 in respect to patient total
calcium (CaT) uptake and change in serum calcium fractions. Three
patients were studied 3 times each during A and B hemodialysis using
polysulfon capillary filters F60. Dialysate composition was: A: CaT 1.75
mmol/liter, acetate 38 mmollliter; B: CaT 1.75 mmol/iiter, bicarbonate
32 mmollliter, acetate 3 mmol/liter. Results (mean sD):
Dialysate A B Significance
Ca' 1.50 0.01 1.42 0.03 P 0,05
Gradient (CaTdjaly,ate
Before . .
After dialysis
Calcium uptake,
mmol/liter
Ca blood; mmol/Iiter)
0.44 0.13 0.55 0.10
0.20 0.08 0.33 0.03
9.20 1.74 3.57 4.73
NS
0.05
NS
Blood CaF (after dialCa' ysis), mmol/liter1.71 0.06 1.57 0.01 P 0.05
Main results include a lower Ca in B dialysate, a higher gradient at
the end of B treatment, no significant difference in Ca uptake due to
large variation during B treatment, and a significantly higher Ca + after
A dialysis. Correlation studies between gradient and calcium uptake per
100 ml of blood passing the filter showed higher transfer of calcium
during A than B treatment at gradients <0.5 mmol/liter. It is concluded
that A and B hemodialysis with the same total dialysate calcium content
results in lower end treatment Ca' + blood concentrations which might
predispose to secondary hyperparathyroidism. The amount of calcium
uptake during both modes of hemodialysis treatment is small.
Kidney function after "customary" protein load: Clearance study and
microalbumin excretion rate. U. Binswanger, 1. Hofrnann, M. Hugen-
tobler, G. Keusch, J. Lattmann, J. Peters, W. Probst, U. Widrner,
Nephrologische Station, Departement fur Innere Medizin, 8091 Zurich,
Switzerland. Dietary protein in high doses is known to increase renal
blood flow and glomerular filtration rate in normal man; its role for
progression of renal failure is suggestive. This study was initiated in
order to evaluate excretory kidney function and microalbumin excre-
tion rate after a "normal" protein load. Volunteers were the nephrology
crew listed above, considered to represent a group of people with
normal kidney function. Serum and urine chemistry of a 2-hour sam-
pling period was studied twice starting 1 hour after a lunch with salad
and steak (200 g 40 g of protein) and 4 days later after a "salad only"
meal. Hydration included mineral water ad libitum. Results were as
follows (mean SD):
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® Protein (9
Serum creatinine janollliter 89.5 10.8 94.6 13.7"
Urea excretion rate mmol/nzin 0.24 0.07 0.31 0.07"
Creatinine clearance mI/mm 95.2 18.2 109.0 26.7"
Albumin excretion rate mg/mm 0.02 0.02 0.03 ØQ35
®vs (9 protein, paired t-test P < 0.05; b NS
There was a correlation between creatinine clearance and urea excre-
tion in urine (r = 0.72), but no relationship to salt excretion. These data
demonstrate a discrete significant increase of serum creatinine and
creatinine clearance after a usual protein meal, reflecting most likely a
physiologic response. No acute increase in albumin excretion occurred
which might have pointed towards functional damage. Whether re-
peated or chronic protein loading leads to kidney damage without
underlying disease is a matter of debate.
Serum acetate concentrations after short time high flux hemodialysis:
Relationship to hypotonic episodes. U. Binswanger, J. VOgtli, Nephro-
logische Station, Departement fur Innere Medizin, Universitutsspital,
8091 Zurich, Switzerland. Serum acetate levels after hemodialysis
(Polysulfon capillary filter F60, dialysate acetate 35 mmol/liter, flow 500
mI/mm) were estimated in ultrafiltrate of serum samples by means of an
enzymatic kit (Boehringer-Mannheim). According to end dialysis serum
acetate concentrations, two groups of patients exhibiting more or less
than 5 mmollliter of acetate were assigned. Treatment modalities and
patient data were as follows (low vs. high acetate, m SD range).
Serum acetate, mmol/liter; 2.55 1.03 (1.09-4.76) vs. 7.65 2.48
(5.56-11.80); body weight, kg: 62.3 9.9 (47-89) vs. 57.5 14.7 (38-73);
blood flow, ml/min: 243.1 43.9 (200-300) vs. 278.7 38.8 (200-300);
treatment time, hr: 2.96 0.32 (2.5-3,5) vs. 2.67 0.26 (2.5-3,5);
hypotonic episodes, pat/group: 4/13 vs. 2/6. Although tendencies can
be observed indicating that lower body weight, higher blood flow and
shorter treatment time are accompanied by higher end dialysis acetate
levels, the differences between groups were not significant. The fre-
quency of hypotonic blood pressure episodes and the degree of acetate
accumulation was found to be loosely correlated and therefore could
not be used as a predictor of hemodynamic instability in this group of
patients, which did not include cases with liver disease. Short time
high-flux dialysis using acetate as the buffer is an acceptable treatment
mode for the majority of patients.
liz Microgiobulin: Serum levels and removal in high flux hcmodlalysis
(lID) and continuous ambulatory peritoneal dialysis (CAPD) treated
patients. U. Binswonger, J. VOgtli, B. Stutz, Nephrologische Station,
Departement fur Innere Medizin, Universitatsspital, 8091 Zurich, Swit-
zerland, 1 microglobulin levels in serum and dialysate were estimated
using a radioimmunoassay kit (Pharmacia). lID patients underwent 3
treatments for 2.5 to 3.5 hours weekly using a polysulfon capillary filter
(Fresenius F60). CAPD patients exchanged 7.5 to 10 liters daily.
Results are as follows (mean SD):
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Serum concentrations
mg/liter
Removal
mg/day
HD (N = 9) 22.00 8.22a 50.04 17.40
CAPD (N = 13) 25.10 7.41 33.22 9.99
a Mean value of estimations before and after dialysis
Mean hemodialysis filter clearance as calculated from the amount of 132
microglobulin recovered in total dialysate divided by mean serum
concentration before and after treatment and time of therapy was 30.5
3.0 mi/mm. The distribution volume estimated from the amount
removed, calculated as distribution volume times concentration de-
crease, was 18,1 2.4% of body weight, reflecting closely extracellular
fluid space. 132 microglobulin production rate as calculated in hemodi-
alysis patients from pre- and post-dialysis serum concentrations were
similar to the daily removal in CAPD patients under stable conditions;
it amounted to about 1/3 generated in kidney intact controls. Both
dialysis procedures investigated remove similar amounts and result in
comparable p2 microglobulin serum levels.
Oxalate removal during high flux hemodialysis (HI)) and continuous
ambulatory peritoneal dialysis (CAPD) treatment. U. Binswanger, J.
VOgtli, B. Stutz, Nephrologische Station, Departement für Innere
Medizin, Universit/itsspital, 8091 Zurich, Switzerland. Oxalate reten-
tion was found by others to occur in renal insufficiency and to be of
importance by its deposition in many organs. We studied serum oxalate
levels and removal by HD (Polysulfon capillary filter F60) and CAPD
(10 liter exchange) by estimating oxalate in ultrafiltrates of serum or
dialysates using a modified colorimetric method according to
Hodgkinson. Results were as follows (mean SD):
Patients
Serum level
mmo!/liter
Removal
mmol/day
HD (N = 16) 0.134 0.045 1.47 0.51
CAPD (N = 14) 0.118 0.019 0.93 0.25
a HD vs. CAPD, P < 0.001
Serum oxalate levels before HD and during CAPD were similar for the
two treatment modes investigated, in spite of higher removal rate during
HD treatment. Whether different buffers (acetate vs. lactate) are
involved has to be investigated. Serum concentrations studied in 4 HD
patients on and off vitamin C supplements during unchanged dialysis
treatment were 0.171 0.050 and 0.083 0.029 mmol/liter respective-
ly, indicating restricted use of vitamin C for supplementation to be
appropriate.
AIDS in a renal graft recipient. V. Briner, J. Landmann, F. Brunner,
M. Molzahn, G. Thie!, Kantonsspital Base!, Universitatsklinik,
Nephrologie, Basel, Switzerland. Screening with ABBOTT HTLV LII
EIA gave positive results in 5 of 140 (3.6%) recipients of kidney grafts
(KG) in Basel. The presence of anti—HIV antibodies was confirmed in
a single case (0.7%) by immune-enzymatic technique (ELAVIA) and
Western blotting. This 68-year-old female is one of 3 HLV positive KG
recipients who have been observed in Switzerland and the only case
where the virus was transmitted by the KG. Transplantation (May 1984)
and postoperative course were uneventful with normal KG function up
to the present time. Continuous cyclosporine (CsA) with initial low
dose prednisone tapered to zero within 6 months was used for im-
munosuppression. The patient still feels excellent but the following
complications were observed: reactivation of latent CMV infection,
slowly but continuously progressing splenomegaly, thrombocytopenia,
hypergamma-globulinemia. The patient had a slight fever of unknown
cause for 2 months in 1986, and herpes zoster and Candida stomatitis in
1987. In Berlin the HIV virus was transmitted (1984) by the KG in 4
patients, too. One patient lost the KG for rejection within the first
month; now generalized lymphadenopathy. The 3 others are on CsA,
and as our patient they are without symptoms and feeling well (Nov.
1987). In our patient the helper/suppressor (H/S) ratio varied between
0.7 and 0.89. Complete allergy to multiple antigens (skin-test Mërieux)
was documented repeatedly. The same immunological tests were per-
formed in 10 HIV antibody negative, randomly-selected KG recipients
on CsA monotherapy. Four of 10 had a H/S ratio below 1.0, 4 had a
helper cell count below 400 x 109/liter, 4 were allergic or barely reacted
to Multi-test Mérieux. Only I of the 10 showed normal results in all
three tests. We conclude: 1.) EIA ABBOTI' HTLV III is in 3.6% of 140
recipients of KG with positive results, and 4 of 5 false-positive
reactions; 2.) 4 patients with HIV virus infection by the KG and on CsA
have a mild course of the infection for more than 3.5 years; 3.) H/S
ratio, helper cell count and skin testing are of little use for staging HIV
infections in patients on CsA.
Maturation of renal function in newborn infants. A. Bueva, P. Wiesel
and J.-P. Guignard, Unite de Nephrologie, Service de Pédiatrie,
CHUV, 1011 Lausanne, Switzerland. The plasma creatinine concentra-
tion is elevated at birth, and decreases concomitantly with the rapid
increase in GFR that occurs in the first postnatal weeks. The velocity of
these changes in relation to the infant's gestational age (GA) was
assessed during the first month of life of 70 term and preterm infants.
The plasma creatinine concentration, creatinine clearance and sodium
fractional excretion were measured serially at weekly intervals. Infants
were separated in four groups according to their birth weight: group 1
(1001 to 1500 g), group 2(1501 to 2000 g), group 3(2001 to 2500 g), group
4 (> 2501 g). Mean gestational ages in the preterm groups were 31.3,
32.8 and 34.5 weeks. The plasma creatinine concentration on day 1 was
significantly higher in preterm (90 9 smol/liter) as compared to term
infants (67 3 molIliter), and correlated significantly with gestational
age (plasma creatinine = 206.5 + 3.5 gestational weeks; r = 0.59; P <
0.001). The differences in plasma creatinine were still present during the
second week of life, with values of 63.5 5.0, 57.7 7.2, 47.1 8.0
and 40.3 4.4 smol/liter in groups 1, 2, 3 and 4. On day 1, creatinine
clearance correlated positively with gestational age, amounting to 0.65
0.14, 0.91 0.13, 1.44 0.30 and 3.9 0.30 mllmin in the four
groups. Creatinine clearance increased rapidly with postnatal age, the
velocity of the maturation being less marked in the most premature
infants. The fractional excretion of sodium was significantly higher in
the most premature infants, with values of 2.0 0.3, 2.2 0.5, 1.1
0.2 and 0.3 0.1% in the four groups. The differences vanish by the
third week of life. The negative correlation between plasma creatinine
at birth and gestational age suggests that the neonate's creatinine
plasma concentration does not simply reflect the mother's plasma
concentration.
Evidence for a mediating action of IGF-I (somatomedin C) in the effect
of growth hormone on renal phosphate (Pi) transport. J. Caverzasio,
J.-P. Bonjour, Division Clinical Pathophysiology, Department Medi-
cine, University Hospital, CH-1211 Geneva 4, Switzerland. In several
physiological and pathophysiological situations growth and growth
hormone (GH) appear to stimulate the tubular Pi reabsorptive capacity
(maxTRPi/ml GF). However, there is no evidence that this stimulation
of renal Pi transport results from a direct effect of growth hormone at
the kidney level. In the present in vivo and in vitro studies we explored
whether IGF-I could be the mediator of GH on renal Pi transport. In
vivo, in hypophysectomized rats, chronic infusion of recombinant
IGF-I (2.5 mg/kg/day) increased body weight (LGF-I: +9.8 1.1;
vehicle: +3.8 1.3 g/week; P < 0.005) and maxTRPi/ml GF (IGF-L:
3.50 0.16; vehicle: 2.78 0.14 mol/ml; P < 0.01). In vitro, in
confluent opossum kidney (OK) epithelia, IGF-I (5 x 10b0 to l07M)
induced a dose-related stimulation of the Na-dependent Pi transport
(NaPiT). A maximal response was observed at lO M (IGF-I 2.75
0.06; vehicle: 1.89 0.02 nmol/mg prot. 4 mm, P < 0.001). Insulin
stimulated NaPiT, but only at concentrations 20 to 40 times higher than
IGF-I. The effect of IGF-I on NaPiT was detectable in less than 30 mm
with maximal response after 4 to 5 hr. It was selective for NaPiT, since
the Na-dependent alanine transport was not altered. Cycloheximide-
inhibition of the de novo synthesis of protein markedly attenuated the
stimulatory effect of IGF-I on NaPiT. The cellular cAMP content was
not modified by the growth factor. The effect of IGF-I could involve a
stimulation of tyrosine kinase. Indeed, vanadate, a compound influ-
encing the phosphorylation of tyrosmne, mimicked the effect of IGF-I on
NaPiT. In conclusion, these observations suggest that growth- and
GH-related changes in renal Pi transport could be mediated by IGF-I
(somatomedin C). This growth factor could increase the synthesis of Pi
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transporter units via a mechanism involving a change in tyrosine kinase
activity.
Endogenous digitalis-like natriuretic factor in pre-ascitie liver cirrhosis.
M. Cunningham, P-f. Male, F. Loizeau, H. Favre Departement de
Médecine, Hôpital Cantonal Universitaire, Genéve, Switzerland. The
mechanisms underlying the sodium retention in liver cirrhosis are
incompletely elucidated. There exist at least two so-called natriuretic
factors: the atrial natriuretic peptide and the endogenous digitalis-like
natriuretie factor (EDNF), which inhibits Na/K ATPase. We decided to
test the hypothesis that there might exist a deficiency of EDNF in liver
cirrhosis. Eight normal volunteers and S patients with biopsy-proven
liver cirrhosis were tested. The absence of ascites was confirmed by
ultrasoaography. The subjects were tested supine, after an overnight
fast. After a 2-hour equilibration period, natriuresis and serum EDNF
were measured hourly for 6 hr. ENDF was measured by an ouabain
displacement assay. Natriuresis was reduced in the cirrhotics compared
to controls (7.69 2.93 SCM vs. 13,61 2.21 mmollhr; P C 0.01).
However, serum EDNF was higher in the cirrhotics (201.03 16.26
5CM vs. 157.73 11.0 nmol/liter) than in the controls, but this difference
was not significant (P = 0.08). Apart from one outlyer, there existed a
negative correlation between serum EDNF and natriuresis (r = 0.95, P
<0.01), whereas there existed no correlation at all in the control group.
Conclusions: Serum EDNF is not reduced in early liver cirrhosis.
However, the eirrhotics with the least natriuresis have higher serum
EDNF, suggesting a resistance to the effects of FDNF.
Beta2-microglohulln kinetics during hemodialysls and hemofiltration.
H. J. Deuber, W. Schulz, A. DOrfier, R. Kohlhaas, G. Ohrisch, 111.
Med. Klinik, Klinikum Bamberg, Bamberg, Federal Republic of Ger-
many. The correlation between beta2-microglobulin ($2M) and the
dialysis associated amyloidosis is well established. There are many
results indicating different concentrations of /32M depending on the
different dialyzer membrane materials used during hemodialysis. The
aim of this study was to investigate the amount of /32M removed during
a single hemodialysis. In 15 patients, aged 45-71 years, being hemo-
dialyzed since 10 to 35 months with different membrane materials, each
one used for at least 20 hemodialysis sessions, the beta2-mieroglobulin
concentrations in plasma were measured before and after dialysis.
Additionally the /32M concentrations were measured in dialysate.
Before After
Number
.
Dialysate
mg/liter Numberhemodialysis mg/liter
Cuprophan 38 10 46 IS 10 0.03 2
Polyamide 28 10 15 5 S 0.50 2
The removal of IhM was significantly (P < 0.05) higher during
hemofiltration with polyamide membrane material than during hemodi-
alysis with cuprophan membrane material. Therefore the plasma p2M
concentrations were significantly (P < 0.05) lower in patients treated
with polyamide membrane material than in those treated with eupro-
phan membrane material, as well before as after hemodialysis/
hemofiltration. Conclusion. Because of the better thM removal, high
flux dialyzers of polyamide should be used as far as possible and
euprophan membrane material should be avoided because of the bad
thM removal.
Improved balance of acidosis in hemodialysis patients by means of
biofiltration. H. J. Deuber, W. Schulz, III. Med. Klinik, Klinikum
Bamberg, Bamberg, Federal Republic of Germany. There are many
different efforts to correct the acidosis of dialysis patients. A new
approach to this goal is provided by means of biofiltration (BF), a kind
of combination of hemodialysis and hemofiltration (Hospal, FRG) using
an acetate dialysate and substituting volume by bicarbonate solutions.
Four patients, aged 52-70 years, being hemodialyzed since 6-55 months,
having aeidosis (pH 7.21-7.31) despite of antiacidotic therapy were
switched over to bioflittation. During biofiltration 300 mval bicarbonate
were administered by volume substitution of 300 ml sodium bicarbonate
solutions, The course of pH during biofiltration was studied, During 1W
there was an improvement of cardiovascular stability. After 3 BF
treatments there was a stabilization of pH during the interdialytic
interval.
pH
Before 1W
After 20
mm BF
After 40
mm BF
After 4
hours BF
1W 1-3 7.28 0.03 7.36 0,04 7.39 0.05 7.49 0.02
BF 4 etc. 7.37 0.04 7.36 0.03 7.40 0.02 7.49 0.03
Conclusion. These preliminary results suggest that BF is a form of
dialysis that improves acidosis in dialysis patients. Additionally BF
seems to produce a better cardiovascular stability of patients compared
with acetate and bicarbonate dialysis.
Pharmacokinetics of chinolone antibiotics in patients on maintenance
hemodialysis. A. Darfier, H. J. Deuber, W. Schulz, R. Kohl haas, H. G.
Muhlbauer, G. Ohrisch, F. Burkhardt, G. Hopf, R. Bocker, III. Med.
Klinik, Klinikum Bamberg, Bamberg; Landesuntersuchungsamt für das
Gesundheitswesen /Vordbayern, Erlangen; Pharmakologisches Inst itut
der Universitat Erlangen, Erlangen, Federal Republic of Germany.
Chinolone antibiotics are well established. They are used because of
their good efficacy in treatment of tissue infections. This study was
done to demonstrate the efficacy and the pharmaeokineties of
ciprofioxaein (Ciprobay, Bayer AG, Leverkusen, FRG) and of
ofloxacin (Tarivid, Hoechst AG, Frankfurt, FRG) in hemodialysis
patients that had infections of venous lines or of dialysis shunts. Ten
patients, aged 44-66 years (ofloxacin) and 30-70 years (eiprofloxacin),
being on hemodialysis were treated with daily doses of 200 mg
ciprofloxacin and 100 mg ofioxacin respectively for 5 days. Before
administration of the drug, 1 hour, 6 hours and 10 or 12 hours thereafter
blood samples were taken to measure the concentrations of the
chinolones by HPLC (ciprofloxacin) or bioassay (ofloxacin). Also the
dialysate concentrations of the chinolones were measured.
Half-life time
Removal during
dialysis
First
administration
Steady
state
hours mg
Ciprofloxacin 35 63 15
Ofloxacin 13 48 34
The clinical efficacy was comparable in both drugs. Adverse side effects
could not be detected. The half-life time of ciprofioxaein was longer
compared with ofloxacin. The loss of ofloxacin during dialysis was
higher than the loss of ciprofloxacin. Conclusion. Treatment with 100
mg ofloxacin (orally) and with 200 mg ciprotloxaein (intravenously) is
efficient in eradicating infections within 5 days. The doses used are
sufficient to substitute the losses during hemodialysis.
Esishllshment of a rabbit kidney epithellal cell line derived from S2
segments of the proximal tubule, Christine Fauth, Michel Claire,
Danielle Chabardes, Jean-Pierre Kraehenbuhl, Heidi Diggelmann,
Bernard Rossier, Fran Roch-Ramel, Institut de Pharmacologie,
Université de Lausanne, Switzerland; Faculté de Pharmacie de
Montpellier, France; institut Suisse de Recherche Expérimentale sur le
Cancer, Epalinges, Switzerland; College de France, Paris, France. The
aim of this study was to establish epithelial cell lines derived from
defined nephron segments. Primary cultures were prepared from dis-
sected proximal straight tubules, S2 segments, of the rabbit kidney and
grown in monolayers. Immortalization was observed after nuclear
mieroinjection of the cells with simian virus 40 DNA and resulted in the
development of an epithelial cell line which was maintained in culture
during over one year, (>40 passages) Electron microscopy indicated
that the cultures were composed of a monolayer of polarized epithelial
cells. When the epithelia were grown on plastic dishes, domes were
often observed, indicating fluid and solute transport. When grown as
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monolayers on collagen-coated filters the cells showed a transepithelial
resistance of 80 ohm cm2 and no significant potential difference.
They were able to accumulate tetraethylammonium, an organic cation.
We conclude that this cell line shows characteristics of epithelial cells
and has maintained certain cell's properties of intact proximal tubules,
such as the transport of organic cations. Using various individual
oncogenes and/or combinations of different oncogenes, the present
methodology should allow us in the future to develop renal epithelial
cell lines of defined origin and with specific functional properties.
Withdrawal of steroids after cadaveric kidney allotranspiantation on
maintenance triple therapy. D. Frei, G. Keusch, F. Largiader, U.
Binswanger, Nephrologische Station Departement fur Innere Medizin
und Departement für Chirurgie, Universitätsspital, 8091 Zurich, Swit-
zerland. Withdrawal of steroids after cadaveric kidney transplantation
was shown to result in both deterioration of graft function and excellent
long-term function. To reduce the serious steroid side-effects, a proto-
col was followed to taper the steroid dosage gradually to discontinua-
tion in recipients with a well functioning graft maintained on triple
therapy with low-dose cyclosporine, azathioprine and prednisone.
Among 181 renal allografts performed between March 1984 and March
1987, prednisone was discontinued in 116 patients with good graft
function 6 months after transplantation. The remaining patients showed
unstable graft function or had experienced recurrent rejection episodes
and therefore no attempt was made to discontinue prednisone. In 82 out
of 116 patients withdrawal of prednisone was successful, with un-
changed serum creatinine values 3 weeks after withdrawal (125 vs. 128
smol/liter), whereas in the remaining 34 patients prednisone had to be
reinstituted because of an average rise of 45% in serum creatinine 6
weeks after withdrawal (128 vs. 186 mol/liter). In the latter group, 25
patients reached the same serum creatinine value 6 weeks after
reinstitution as before withdrawal of prednisone (128 mollliter), 7
patients were able due to reinstitution to stabilize the graft function,
although on a higher serum creatinine level than before withdrawal (129
vs. 168 mol/1iter), and 2 patients lost the graft 35 weeks and 14 months,
respectively, after withdrawal because of chronic rejection despite
reinstitution of prednisone. The number of incompatible donor HLA
antigens was examined to test whether steroid requirement was corre-
lated with the number of mismatches. Furthermore, graft survival and
serious side effects in both groups were analyzed. The study has to be
extended in order to decide whether statistical correlation exists. In
summary, in the present study prednisone could be abolished in 45% of
renal transplant patients maintained on triple basic immunosuppressive
therapy 6 months post transplantation. We conclude that: I) steroids
should only be withdrawn from patients on maintenance triple therapy
with normal, stable graft function under close control of serum creati-
nine levels, and 2) steroids should be reinstituted immediately in the
case of rising creatinine values after withdrawal.
Characterization and localization of ecto-5'-nucleotidase in rat kidney.
R. Gandhi, T. Dawson, B. Kaissling, M. Le Hir, U. C. Dubach.
Medizinische Universitats-Poliklinik and Anatomisches Institut, Basel,
Switzerland. The membrane bound ecto-5'-nucleotidase (5'-Nu)
dephosphorylizes 5'-AMP to adenosine, which plays an important role
in renal hemodynamics and possibly in tubuloglomerular feedback. We
purified and localized the enzyme of rat kidney. 5'-Nu was extracted
with detergents from a membrane fraction and purified 9,000-fold by
affinity chromatography with concanavalin A-sepharose and ADP-
agarose. The molecular weight of the subunit, determined by SDS-
PAGE, was 67,000. The Km for 5'-AMP was 5.1 M. The pH activity
curve showed a plateau from 6.8 to 8.0. Competitive inhibition was
observed with ATP (K1: 1.2 M) and ADP (K1: 0.32 SM). The enzyme
was active without added divalent cations, but it was inhibited by
EDTA. These findings show that the renal 5'-Nu was similar to 5'-Nu
from other organs. Localization of the enzyme in cryostat sections was
carried out by enzyme histochemistry and by immunohistochemistry(fluorescence, PAP) with polyclonal antibodies raised in rabbits. The
two methods yielded the same pattern. 5'-Nu was localized in the brush
border of the proximal tubule (P1 >P3>P2). The intercalated cells were
positive in the distal tubule and in the cortical and outer medullary
collecting duct. Other tubular structures, as well as the glomeruli are
negative. Strong activity and antigenicity are found in the peritubular
and perivascular tissue of the cortical labyrinth. With respect to the role
of adenosine in the regulation of hemodynamics, the high activity in the
peritubular and perivascular tissue may be of particular significance.
Continuous pulse oxymeter studies during hemodlalysis treatment. Y.
Gilli, U. Binswanger, Nephrologische Station, Departement für Innere
Medizin, Universi:atsspital, 8091 Zurich, Switzerland. Continuous
pulse oxymetry for estimations of oxygen saturation were performed in
38 patients dialyzed 3 times a week during 2.5 to 4 hours using
polysulfon capillary filters (F60). The whole group showed a significant
depression of SO by 1.9% of the base line value. Seven patients studied
repeatedly (more than 3 studies) exhibited a significant mean decrease
of SO2 from 1.5 to 4.2%, mostly occurring during the first 60 minutes of
treatment. Short term depression of SO2 occurred by 6 to 9% during
sleep, speech, coughing or vomiting. The evaluation of severe blood
pressure drop was not possible due to lack of measuring signal at
peripheral sites. Short term changes of SO2 without clinical signs
included: temporary drop of SO2 during 1 minute by 3 to 22% in 3
patients; abrupt or slowly developing depression of SO2 by 3 to 6% and
establishment of a new lower level during 20 to 60 minutes in 3 patients;
episodes of 20 to 60 minutes duration occurring in the second half of the
dialysis session exhibiting short term depression by 6 to 10% and a
reduction of SO2 by 2% alternatively were observed in 3 patients;
instability of SO2 readings and changes up to 8% during the whole
treatment were observed in 4 patients. Short time disturbencies oc-
curred when registered simultaneously on one finger of both hands.
Observations were not significantly influenced when using cuprofane
instead of polysulfon filters, during bicarbonate instead of acetate
dialysis, and by filtering the blood before the dialyzer. Pulse oxymetric
findings were verified by conventional blood 02 analysis. Small changes
of SO2 reflect much larger variations of P02, this relationship being
influenced further by 2, 3 DPG, Pa CO2 and pH. Our data indicate that
relative changes of oxygen supply occur during dialysis and can be
divided into long term effects and short term alterations. They might
contribute to incompatibility of the dialysis treatment. The continuous
monitoring points to the difficulty of interpreting single measurements
during dialysis.
Cardiovascular and renal effects of low dose dopamlne after open heart
surgery in pediatrics are age related. E. Girardin, M. Berner, H. Favre,
M. Vallotton, J. C. Rouge, B. Fried/i, L. Paunier. Clinique de Pédi-
atrie, Hôpital Cantonal Universitaire, Genève, Switzerland. Eleven
patients, 2 to 15 years old were studied 3 to 4 hours after the end of
cardiopulmonary bypass during a control period (1-1/2 hr = C) and
during two periods of continuous infusion of dopamine: 2.5
microglkg/min (1-1/2 hr = Dl) and 5 microg/kg/min (1-1/2 h = D2). No
other cardiovascular medication was administeted. Cardiac output was
measured by thermodilution using a Swan-Ganz catheter. Clearances
were measured using standard inulin and PAH techniques. Cardiac
index increased from 2.91/min/m2 (C) to 3.01/minim2 (Dl) (P = NS)and
to 3.21/minim2 (D2) (P < 0.05). The magnitude of the increase was
linearly correlated with the age of the patients, the older the patient, the
bigger the response (P = 0.25: C to Dl; P = 0.02: Dl to D2). Renal
blood flow (RBF) increased by 12% from C to Dl (P = NS) and by 20%
from Dl to D2 (P < 0.01). The magnitude of the response was also
correlated with the age of the patients (P = 0.004: C to Dl; P = 0.01: Dl
to D2). The ratio of RBF to cardiac index was 7% at C, 8.7% at Dl and
10% at D2 indicatiig an effect of dopamine on RBF unrelated to the
effect on the cardiac index. Inulin clearances were 81 ml/min/l .73 m2
during C, increased to 83 rnl/min/l.73 m2 at Dl (NS) and increased to 97
mI/mm/I .73 m2 at 02 (P < 0.025). Urinary sodium excretion (UNa)
increased from 0.27 mmol/kglhr at C to 0.29 at Dl (P = NS) and to 0.43
at D2 (P < 0.05). The magnitude of the increase was significantly related
to the age between C and Dl (P = 0.049) but the response between Dl
and D2 was not age related. Plasmatic concentrations of atrial natri-
uretic factor (ANF) were elevated in all the periods: 249 I 223 pglml at
C, 257 223 pg/ml at Dl and 282 179 pg/ml at D2 and were not related
to UNa. These results indicate an age related maturation or evolution of
the response of the various adrenergic receptors.
The newborn rabbit: A model of Bartter syndrome. J.-P. Guignard, 0.
Grigoras, A. J. v.d. Heijden, Unite de Nephrologie, Service de Pédi-
atrie, CHUV, 1011 Lausanne, Switzerland. Renal regulation of acid-
base balance was studied in 40 rabbits aged 5 to 12 days, raised with
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their mothers and breast-fed until the experimental day. The normal
newborn rabbit is in a state of hypochloremic metabolic alkalosis
(plasma HC03 = 31.9 0.6 mmol/liter, plasma Cr = 83.1 1.0
mmol/liter), and excretes an alkaline (pH = 7.40 0.15) relatively
hypertonic (osmolality = 578 41 mOsmlkg I1O) urine containing 50
9 mmol/liter C1 and 13.2 3.8 mmol/liter Nat The occurrence of
a relatively high fractional excretion of Cl— (1.38 0.25%) in compar-
ison with Na (0.89 0.12%) in the preseace of marked hypochloremia
suggests chloride wasting. The rabbit's milk on days 3-8 has a pH value
of 6.72-7.00, contains small amounts of HC03 (1.8-4.4 mmol/liter) and
substantial amounts of chloride (39-45 mmol/liter), sodium (37-46
mmol/liter) and potassium (40-50 mmol/liter). The maintenance of
slightly-elevated plasma potassium levels is probably explained by the
high potassium content of the milk. The alkaline load in the milk
appears to consist of calcium carbonate compounds, potential genera-
tors of HC03 in the intestine. The concomitance of volume contrac-
tion, sodium avidity and hypochloremia is probably responsible for the
perpetuation of the metabolic alkalosis.
Treatment of severe nephrotic syndrome unresponsive to corticoste-
roids with cyclosporln A. H. Heule, F. W. Reutter, H. Gantenbein.
Medizin B, Kantonsspital, 9007 St. Gallen, Switzerland. Seven adult
patients with severe corticoid-resistant nephrotie syndrome (NS) were
treated with cyclosporin A (CsA). CsA serum-levels in the range of 200
to 400 pg/liter were attempted. Five pts. had membranous glomerulo-
nephritis (ON), 1 pt. had systemic lupus erythematodes (SLE) with
mesangioproliferative GN and 1 pt. had SLE with membranoprolifera-
tive ON. Proteinuria ranged from 10.9 to 25.0 W24 hr. Five pts. (4 pts.
with membranous ON and I pt. with SLE and membranoproliferntive
GN) showed under CsA-treatment partial remission of NS with de-
crease of proteinuria from 16.4 5.4 to 2.7 1.5 g/24 hr. This remission
so far lasted for 12 months. Total serum protein increased from 45.4
6.3 to 61.8 7.9 g/liter. CsA was discontinued in 2 pts. after 6 weeks
due to unresponsiveness of proteinuria (1 pt. with membranous ON and
I pt. with SLE and mesangioproliferative ON). The 4 pts. with initially
normal renal function (creatinine <130 jzmol/liter responded to CsA in
contrast to only 1 of 3 pts,. with initially decreased renal function
(creatinine 270 to 375 imol/liter). The renal function of the 5 pts. with
partial remission of NS remained stable. Renal function of the 2
non-responders deteriorated to a ereatinine of 690 smo1Iliter in one case
and to the point of requiring dialysis in the other. Conclusion. Steroid
resistant NS in adults responds well to CsA-treatment especially in pts.
with normal renal function. In the absence of complete remission
decrease of proteinuria led to disappearance of edema and by increasing
of serum albumin abolished the need of anticoagulation. CsA-treatment
further seems to have a positive influence in maintaining the renal
function.
Does intrauterine diuretic applIcation Influence renal differentiation?
M. Hropot, R. Seufert, F. Casper, G. Bartzke, Universitatsfrauen-
klinik, Mainz; Hoechst-AG, Frankfurt, Federal Republic of Germany.
To evaluate renal changes induced in the fetus, 3 groups of 25 gravid
rats each were treated with 100 mg chlorthalidone and 40 mg
furosemide/kg/day. Group I was treated during the entire pregnancy,
group 2 during the first half and group 3 during the second half.
Twenty-five untreated rats served as controls. One rat of each litter was
examined after 6 weeks (N = 100). Free-flow micropuncture was done
in 5 male rats of each group (N = 20). The remaining animals were
studied morphometrically and the results statistically analyzed by the
multivariance test. The SNOFR was lowered in the superficial nephrons
of group I and 2 (more pronounced in the latter). Sodium reabsorption
down to the end of the proximal tubule was clearly reduced in group 1.
Furthermore, significant potassium secretion was found in the area of
the collecting tubes of this group. Only group 3 showed higher serum
renin activity, while the proximal tubular profile increased significantly
in all treated groups, In group I a significant decrease in lomernlnr area
and a significant increase in the relationship of number of cell nuclei to
profile area in the distal and proximal tubule were seen. Conclusion.
These animal experiments showed that diuretics applied during preg-
nancy result in significant morphological and functional changes in the
infant kidney.
Dilatation of the fetal ureter after Induced intrauterine diuresis. M.
Hropot, R. Seufert, F. Casper, G. Bartzke, Universitdtsfrauenklinik
Mainz, Hoechst-AG Frankfurt/Main, Federal Republic of Germany.
The etiology of most sonographically detected dilatations of the
intrauterine renal pelvis and ureter is unknown. Observations of ure-
teral dilatation related to congenital diabetes insipidus has led to the
suspicion of at least a modifying influence resulting from intrauterine
diuresis. To increase fetal diuresis experimentally, gravid Wistar rats
were treated with 100 mg chlorthalidon and 40 mg furosemide per kg
body weight per day. Twenty rats of each group were treated, Group 1
during the entire course of gravidity, Group 2 during the fist half and
Group 3 during the second half. Group K was the untreated control
group. For morphometric investigation 9 equidistant sections of each
ureter were prepared. Circumference, and submucosal, muscle and
urothelial thickness were determined and evaluated by means of
variance analysis. Statistically significant changes were found only in
the uppermost third of the ureter. Circumference increase was highly
significant in all treated groups (Group 1 50%; Group 2 60%; Group 3
70%;). Similar behavior was seen in muscle and urothelial thickness,
while submucosal thickness remained constant. Neither side- or sex-
related effects could be determined. All treated groups reacted similar-
ly. On the basis of these results, however, it does not appear necessary
to require complete restriction of diuretics during pregnancy.
Chronic cyclosporin A (CsA) nephroto*lclty in allogeneic bone marrow
transplant recipients. B. Huser, M. J. Mihatsch, A. Gratwohl, B. Speck,
0. Thiel, Division of Nephrology and Hematology, Department of
Internal Medicine and Department of Pathology, Kantonsspital Basel,
Switzerland. In 9 randomly-selected patients (pts) (6 males, 3 females;
mean age 31 years) with an elevated plasma creatinine, kidney biopsies
together with clearances of inulin (C10) and creatinine (Ccr) wore
performed. All pts were conditioned and treated according to the same
protocol. All were under continuous CsA therapy. The investigation
was done between 3 and 76 months (mean 33 months) after transplan-
tation. Histological findings were compared and correlated with plasma
creatinine, clearances and CsA 24-hours whole blood trough levels.
Plasma ereatinine (normal range 7 1-133 bsmol/Iiter) was slightly higher
at time of biopsy (112 34 pmol/liter) in comparison to the values
obtained 1 day before transplantation (79 17 izmol/liter (Pc 0.05). C1
were decreased in all pts (60 13,9 mllmin/l.73 m2) as well as Cc,. (71
15 mI/mm/I .73 m). Histological examination revealed CsA associ-
ated arteriolopathy (CAA) with striped interstitial fibrosis in 8 out of 9
pts, severe in 5 pts and mild in 3 pts. In one pt no signs of chronic
nephrotoxicity were found. Percentage of completely obsolescent gb-
meruli ranged from 0 to 55% and correlated with the time of CsA
treatment(r = +0.791,P <0.01) C10 and Cc,. did not discriminate cases
with severe CAA from cases with a mild degree of CAA, and were not
correlated with the percentage of obsolescent glomeruli nor with CsA
blood levels. An elevation of plasma creatinine above baseline by 30%
was found in 4 out of 5 pts with severe CAA, but in only 1 out of 3 pts
with a mild form of CAA. Arterial hypertension exceeding 90 mm
mercury of diastolic blood pressure despite antihypertensive therapy
was diagnosed in 4 of 5 pts with severe CAA. We conclude that a
relevant chronic CsA nephrotoxicity might exist in more bone marrow
transplant recipients than expected. Neither elevation of plasma creat-
me, inulin or creatinine clearance appear to be helpful to predict the
degree of histological damage.
Hypocitraturla often reveals incomplete distal renal tubular acidosis
(dRTA) or unsuspected Intestinal hypermotllity in "idiopathic" stone
formers. Ph. Jaeger, L. Portmann, A, F. .Iacquet, P. Burckhardt.
Depariment of Internal Medicine, University Hospital, Lausanne,
Swiizerland. We recently evaluated the records of the 51 renal stone
formers (SF) whose U-citrate volume on free choice diet had been
found below normal (<215 mg/24 hr) on at least one occasion over the
last 3.5 year period of analyses (Jan. 1, 1984—June 1, 1987). After
exclusion of the cases on thiazides (N = 7) or on acetazolamide (N = 3),
of the cases with chronic diarrhea (N = 9), with complete dRTA (N =
4)or with metabolic acidosis of other origins (N = 3), there remained 25
patients who turned out to be idiopathic SF whose hypocitraturia
generally (N = 17) was an isolated disorder (that is, without concomi-
tant hypercalciuria, hyperuricosuria and/or hyperoxaluria). Since
dRTA and chronic diarrhea were the most frequent causes of
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hypocitraturia, we wanted to investigate whether these 25 cases with
apparently idiopathic hypocitraturia might have subtle and unsuspected
disorders of urinary acidification or of intestinal motility. These "id-
iopathic" hypocitraturics underwent a 3-day NH4CI-loading test (4.8 g
day, p.o.) followed on day 4 by venous blood and fasting urine
samplings for HCO3 and pH measurements. Seven patients had an
abnormal response to the test, compared with results of 17 normal
subjects; their urine pH did not sufficiently decrease, considering the
blood HCO3 level obtained at the same time, although in 3 cases urine
pH fell below 5.3. Thus, 7 cases had incomplete dRTA. These "idi-
opathic" hypocitraturics were also asked about apparent intestinal
motility: 6 of them stated that on a regular basis their stools tended to
be unformed, thus suggesting intestinal hypermotility. Finally, 19 of
these "idiopathic" hypocitraturics were treated with alkali given orally
either as K-citrate or Ca-gluconolactate and -carbonate; this maneuver
corrected the hypocitraturia in all of them. Conclusion: idiopathic
hypocitraturia reveals incomplete dRTA and/or unsuspected intestinal
hypermotility in about 50% of the cases. Treatment with alkali corrects
the disorder.
High blood pressure response to exercise as a predictor of hypertension:
Clinical and prognostic value. J. P. Janssens, A. Rostan, H. Favre,
Département de Médecine, Hôpital Cantonal Universitaire, Genève,
Switzerland. Owing to the relatively frequent occurrence of high blood
pressure during dynamic exercise testing in our practice, we decided to
investigate the clinical significance of this observation. Data concerning
normal blood pressure values during exertion are scarce; therefore
mean values 2 s for blood pressure, at a given work load were
calculated per age group (<20 / 20-39 / 40-59 / >60) sex, and workload
for systolic and diastolic pressures. Three hundred and nineteen sub-
jects (192 men and 127 women) were submitted to a dynamic exercise
test on a cycloergometer. BP readings were recorded at rest and during
exertion at 100 and 150 watt workloads. A standard sphygmomanome-
ter was used for BP measurements. Data were computed to calculate
mean values. Hypertension during exertion was defined as systolic
and/or diastolic values which exceed by more than 2 standard devia-
tions mean values for the corresponding age group and sex. Twenty-
three subjects who met these criteria were followed for an average
period of 48 months; their clinical outcome was compared to that of a
control group of 28 subjects, matched for age and sex, but normotensive
at rest and during exertion. The relative risk—for a normotensive
individual with high BP during exertion—of becoming hypertensive at
rest after 4 years was 2.8. The predictive value of an abnormal exercise
test is therefore insufficient to define a "high-risk" group of patients
prone to hypertension in a near future. Plasma ANF concentrations in
17 subjects with high exercise BP were analyzed according to their
clinical outcome. There was a significant difference between mean
values of hypertensive subjects who were still hypertensive after 48
months, and normotensives who stayed normotensives after the same
period (mean SD pg/mI 39.5 14.4 vs. 89.4 30.5, P < 0.001).
However, there is no "cut-off" value allowing a prediction of the
evolution of rest-BP in these patients.
Percutaneous transluminal angioplasty for stenosis of hemodialysis
vascular access. H. Jungbluth, E. Schneider, K. Zaruba, Nierenstation,
Stadtspital Waid Zurich and Abt. Angiologie, Med. Poliklinik,
Universitatsspital Zurich, Switzerland. Since 1985 percutaneous trans-
luminal angioplasty (PTA) for stenosis of hemodialysis vascular access
was performed in 8 patients on maintenance hemodialysis on 11
occasions. Access malfunction was manifested by graft and fistula
elevated venous pressure or decreased blood flow. Arterial and venous
limbs were evaluated by venous fistulography. Findings were stenosis
of segments in the venous limb in all of the patients. In I patient stenosis
of the arterial limb was found, too. Percutaneous transluminal access
dilatation was performed using the standard PTA technique. Success
was achieved in 10 attempts. Once, angioplasty was followed by fistula
thrombosis and a second attempt of PTA was necessary following
thrombolysis by means of urokinase. In the follow up period in 3
patients, surgical intervention was required 3 months, 5 months and 2
years, respectively, after PTA. There were no major complications, no
rupture of the dilated access, no distal embolization, which were related
to PTA. Therefore, we recommend PTA as an efficient nonsurgical
approach to vascular access stenosis.
Microangiopathic hemolytic anemia and acute renal failure in renal
allograft recipients. G. Keusch, H. R. Burger, J. Gmur, U. Binswanger,
Nephrologische Station, Departement für Innere Medizin, Universi-
tatsspital, 8091 Zurich, Switzerland. We observed acute microangio-
pathic hemolytic anemia (MHA), thrombocytopenia and acute renal
failure in 7 out of 152 patients (pts) 2 to 8 days following renal
transplantations (RT) during immunosuppression with cyclosporine
(C5A), azathioprine (Aza) and prednisone (P), and in 2 pts treated with
F, Aza and ATG. In one of them the original renal disease was a
hemolytic uremic syndrome. In another pt MHA occurred 3 years after
successful RT after conversion from P. Aza to P, CsA. Transplant
biopsy (Bx) performed in 8 out of 10 pts revealed the following lesions:
thrombotic microangiopathy (I pt); thrombotic microangiopathy and
CsA-associated arteriolopathy (4 pts); acute vascular rejection (2 pts);
intravascular coagulation in a transplanted shock-kidney (1 pt). CsA
was stopped in all pts except in one, in whom CsA dosage was reduced.
Pts without rejection in the Bx were treated with P pulses, intensive
plasma exchange and replacement of removed plasma with fresh frozen
plasma. In the 2 cases with vascular rejection P pulses and ATG therapy
was instituted. Hematological abnormalities normalized 3 to 11 days
after therapy in all pts and kidney function recovered after 9 to 20 days
in 9 pts. In 2 pts no improvement of kidney function was observed.
Conclusion. MAH following RT was due to various causes: recurrence
of hemolytic uremic syndrome (1 pt); CsA-toxicity (4 pts); vascular
rejection (2 pts); transplanted shock-kidney (1 pt). Therapies outlined
may induce hematological remission and recovery of kidney function.
Regional vascular resistance during different extracorporal treatment
modalities in ESRD. D. Kiss, G. M. Eisenbach, M. E. Wilks, J.
Bahlmann, K. M. Koch, Dialysestation Kantonsspital, 4410 Liestal,
Switzerland; and Div. of Nephrology, Dept. of Medicine, Medical
School Hannover, 3000 Hannover, Federal Republic of Germany. In
order to explain the different behavior of blood pressure during the
different extracorporal treatment modalities of uremia, we studied 13
chronic dialysis patients during acetate hemodialysis (HDA), bicarbon-
ate hemodialysis (HDB), acetate hemofiltration (HFA) and bicarbonate
hemofiltration (HFB), with identical volume removal (2.7 0.5 kg). A
polysulphone hemofilter (F 60) was used for hemodialysis and
hemofiltration. The blood flow rate was set at 300 ml/min. The urea
clearance of hemodialysis was adjusted to hemofiltration by reducing
the dialysate flow rate. Specially prepared sterile dialysate and identical
infusate were used. Blood pressure (MAP) and heart rate were mea-
sured continuously. Calf blood flow (BF) was measured by venous
occlusion plethysmography. The regional vascular resistance (RVR)
was calculated by dividing MAP/BF (mm Hg/ml/min/l00 ml). A signif-
icant decrease of RVR occurred during acetate treatments (especially
HDA) and a significant increase during bicarbonate treatments (Table).
MAP fell significantly in HDA at 60 up to 240 mm (20%) and in HFA at
240 mm (11%), and insignificantly in HDB (4, 5%) and HFB (6%).
RVR:
HDA(N = 13)
HFA
(N = 13)
HD
(N =
B
13)
HF
(N =
B
13)
0 mm 28.8 13.8 31.8 11.3 26.0 11.5 26.8 12.3
30 mm 25.1 12.0 25.6 9.1 27.7 9.6 32.8 16.5
120 mm 17.7 5.7 23.8 8.2 32.2 9.6 33.1 14.1
240 mm 15.5 4.8 26.5 12.7 35.9 13.0 36.4 13.3
Strain gauge plethysmography is a sensitive method for measuring the
changes of peripheral blood flow during hemodialysis and
hemofiltration. In treatments using acetate buffer there is a vasodilator
response despite volume removal in the lower limb during the whole
HD and only initially in HF; using bicarbonate a regional vasoconstric-
tor response takes place in both HD and HF. The kind of buffer appears
to be the main factor responsible for the changes in regional peripheral
circulation, whereas the mode of transport seems to have a modifying
effect in acetate treatments.
How to obtain sterile dialysate. K. Kiss, G.M. Eisenbach, M.E. Wilks,
J. Bahlmann, K.M. Koch, Dialysestation Kantonsspital, 4410 Liestal,
Switzerland and Div. of Nephrology, Dep. mt. Medicine, Medical
School Hannover, Federal Republic of Germany. To optimize the
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quality of conventional dialysate, we performed quality controls of
reverse osmosis water (WRO) and dialysate (D). We measured quanti-
tatively the pyrogea conteat with the chromogenic Limulus amebocyte
lysate test at various sites indicated below and expressed as pg/mI
standardized against in E. coli endotoxin standard. The bacterial
contamination was determined by placing bacterial filters, 0.45 jim
(Millipore) fitted, into filter holders (Swinnex) in the water and dialysate
pathway. In this way up to 5 liters as spot samples for WRO and up to
150 liters as fuli stream samples were obtained. The bacterial filters
were incubated for 48 hrs at room temperature and evaluated for colony
forming units (CFU). Bacterial content was calculated as CPU per liter
sample size. The pyrogen concentration is given as median, bacterial
contamination as percentage of filter discs growing CPU relative to
standard condition. The pyrogen concentration of WRO was 12 pg/nil
and all bacterial samples were positive at point I, being less than 500
CPU/liter sample size on the average. The pyrogen concentration of the
D (I) was 48 pglml and the bacterial controls were all positive (Table I).
By filtering the same WRO at point I, through a polyamide hemofilter
(Gambro FH-88), the pyrogen concentration could be reduced to 4
pg/mI and the bacterial growth to 10% of the previous samples. The
pyrogen concentration of the dialysate was 17 pg/mI; the bacterial
samples were positive in 30% (Table II), both being higher than in
filtered WRO feeding the dialysis machine. Only after placing a
hemofilter in the dialysate pathway could the pyrogen concentration
and the bacterial contamination be significantly reduced. The bacterial
controls were negative for all full stream samples taken; the pyrogen
content was 1 pg/mI. (Table III)
(*p<005)
I (N = 20)
WRO D
Pyrogens pg/mi (median) 12 48
'I,
Bacteria (% of pos. cult.) 100 NS 100*
II (N =20) III (N = 20)
WRO D D
4 17 1
* *
10 30 0
* *
Despite water treatment by reverse osmosis and regular chemical
disinfecrion of the dialysis machine, the dialysate was contaminated
with pyrogens and bacteria. This can be prevented by a filtering system
for the dialysate.
A soluble 5'-nucleotidase in rat kidney. M. Le HEr, R. Gandhi, U.C.
Dubach, Mediz!nische Universitäts-Polik!inik, Base!, Switzerland.
Adenosine participates in the regulation of renal hemodynamics and of
tubular transports, and in tubuloglomerular feedback. The maln source
of adenosine is the hydrolysis of 5'-AMP by 5'-nucleoridase (5'-Nu). A
membrane bound ecto-5'-Nu has been found in the kidney as well as in
many other tissues. We additionally found a 5'-Nu in the high-speed
supernatant of renal homogenates. This enzyme has been partially
purified. It shows some striking similarities with the ecto-enzyme: both
are inhibited by ADP, ATP, and EDTA, both bind to concanavalin A,
and both are inhibited by antibodies raised agalnst the ecto-5'-Nu. This
might indicate that the soluble activity corresponds to an artefact due to
the release of an active fragment of ecto 5'-Nu out of the membrane by
a proteolytic process. However, three findings are hardly compatible
with that explanation. 1) The appearance of 5'-Nu in the high speed
supernatants after various numbers of strokes with the Potter homog-
enizer parallels the appearance of lactate dehydrogenase, a typical
cytosolic enzyme. 2) The distribution of the activity between the high
speed supernatant and the membrane fraction is little dependent upon
the pH of the homogenization buffer. 3) There is no increase of the
activity in the high speed supernatant if the homogenate is allowed to
stand for 70 mm at room temperature instead of being immediately
centrifugated. Moreover, there exists some kineric differences between
the two forms of 5'-Nu. I) The soluble 5'-Nu is about 100 times less
sensitive to inhibition by concanavalin A than the ecto-5'-Nu. 2)
Detergents stimulate the ecto-enzyme but they have no effect on the
soluble one. 3) The K0 for 5'-AMP is 5.1 jiM for the ecto-5'-Nu and 9.5
for the soluble 5'-Nu. In conclusion, the 5'-Nu found in supernatants of
renal homogenates is related to the ecto-5'-Nu, but it seems to be an
authentic soluble enzyme.
Anglotensln II increases renal sodium and water reabsorption in the
absence of aldosterone: A study in intact and adrenalectomized conscious
dogs. M. Marx, 0. Kaczmarczyk, H. W. Reinhardi, Arbettsgruppe
Experimentelle Andsthesie, Klinikum Charlottenburg der Freien
Universitat Berlin und I. Medizinische Klinik der Joh. Gutenberg-
Universitat Mainz, Federal Republic of Germany. Angiotensin II (A II)
plays a major role in the renal regulation of salt and water balance,
mainly mediated by the stimulation of aldosterone secretion. Previous
studies suggest a possible direct A II effect on renal salt and water
excretion. An attempt was made to distinguish the aldosterone-media-
ted from direct A II effects on the kidney. The studies were performed
in 84 experiments on six tralned, conscious female beagle dogs. The
animals were kept under controlled environmental conditions with
standardized sodium intake in metabolic cages. Several instruments
were implanted chronically: catheter in the left atrium, venous catheter,
carotid loop. In three dogs adrenalectomy was performed, with subse-
quent hormone substitution by a portable pump. A II was infused i.v. at
a rate of 0 (control experiments), 1, 4, 20 and 200 ng/min/kg over 60 mm
after a 60 mm control period. Mean arterial blood pressure (MABP, mm
Hg) water excretion (V, jtl/min/kg), sodium excretion (UNav, .smol/min/
kg) and glomerular filtration rate (GFR, mI/mm/kg) were determined.
A II dosage
Before adrenalectomy
MABP V UNaV GFR
0 113± 15 155±41 19.8±7.0 5.1± 1.0
1 120 16 77 208 14.0 4.28 5.1 0.6
4 120 15 43 308 8.9 2.3a 3.8 0.68
20 144 j98 48 478 10.4 7,48 4.1 o.8
200 177 218 111 92 20.4 14.3 4.0 1.0
MABP
After adrenalectomy
V UN8V GFR
114±6 124±54 18.4±2.5 5.2±0.3
112±9 99±14 15.1±2.7 4.5±0.2
130 158 70 348 12.8 4.2a 5.1 0.9155 12 77 41 13.8 7.1 4.3 0.6
172 2P 93 83 17.0 13.8 3,1 0.8
8 Significant difference vs. control experiments P -C 0.025
In intact dogs a dose-dependent increase in the plasma A II and
aldosterone concentration was observed. A significant increase in
plasma vasopressin concentration was only induced by the highest A II
dosage. A II leads to a dose-dependent increase in MABP, which is
more pronounced after adrenalectomy. Urine volume and sodium
excretion decreases during A II infusion in intact and in adrenalecto-
mized dogs; this effect is not abolished after adrenalectomy. The
antidiuresis during A II infusion is not due to a stimulation of vasopres-
sin secretion. The observed increase in water and sodium excretion at
the highest A II dosage may be caused by a pressure diuresis. We
conclude that A II in a physiologic dosage acutely increases renal
sodium and water reabsorption even in the absence of aldosterone.
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Mucosal immunity: Its role in urinary tract infection and renal
transplantation. M. Marx, M. Weber, E. Wandel, K.H. Meyer zum
Bflschenfeide, H. KOhler, I. Med. Klinik der Universität Mainz, Fed-
eral Republic of Germany. Specific IgA-producing cells in mucosal
epithelia provide humoral protection against pathogens in the environ-
ment. Secretory immunoglobulin A (SC-IgA) is the predominant immu-
noglobulin in external secretions and plays a major role in the protec-
tion of mucosal surfaces. However, its role in local defense from
urinary tract infections (UTI) remains to be established. A fast, simple,
sensitive and reproducible enzyme-linked immunosorbent assay was
developed to compare the SC-IgA concentrations in serum and urine of
healthy subjects (N = 40), in patients with recently inserted indwelling
bladder catheter (N = 12), in urinary tract obstruction with cytostomy
and recurrent UTI (N = 14), in urosepsis (N = 5) and in renal allograft
recipients with stable graft function (N = 28). Mean SC-IgA concen-
tration in healthy controls was 23.9 1.5 mg/liter in serum and mean
urinary SC-IgA excretion rate was 0.2 0.03 mg/g creatinine (creat); in
patients with indwelling bladder catheter 88.8 9.1 mg/liter in serum (P
< 0.001), 2.3 0.5 mg/g creat in urine (P < 0.001); in patients with
cystostomy 113.5 16.0 mg/liter in serum (P<0.OOl), 4.3 1.1. mg/g
creat in urine (P < 0.001); in urosepsis 121.5 12.8 mg/liter in serum (P
<0.001), 22.5 5.1 mg/g creat in urine (P < 0.001), in renal allograft
recipients 66.1 1.5 mg/liter in serum (P <0.001), 1,7 0.3 mg/g creat
in urine (P < 0.001). Mechanical irritation induces an increase in
urinary SC-IgA excretion, as was shown in patients with indwelling
bladder catheter. UTI and urosepsis further increases the SC-IgA
excretion. While in UTI the increased SC-IgA excretion rate is thought
to be due to luminal bacterial infection, the highly elevated SC-IgA
excretion rate in patients with urosepsis might be a consequence of
bacterial tissue invasion. The elevated SC-IgA excretion in renal
allograft recipients might be due to postoperative anatomic derange-
ments with chronic urinary reflux. Immunosuppressive therapy does
not reduce the SC-IgA production in the urinary tract. In addition, in all
patients with elevated urinary SC-IgA excretion rate an increase in
serum SC-IgA also was found. These elevated SC-IgA serum levels
may be due to an increased back diffusion of mucosal SC-IgA into the
systemic circulation.
Down-regulation of neutrophils during hemodialysis requires their
contact with the dialyzer membrane. P. Neveceral, M. Markert, J.P.
Wauters. Division de Nephrologie et Laboratoire Central de Chimie
Clinique, CHUV, Lausanne, Switzerland. The decrease of neutrophil
metabolism at the maximum neutropenia during cuprophan (CU) he-
modialysis has been attributed to systemic down-regulation of the cells
by activated complement. To further unravel this mechanism,
neutrophils were simultaneously isolated from the arterial (A) and
venous (V) sties at 1 and 15 mm after the start of dialysis on CU and
polyacrilonitrile (PAN). Neutrophil oxygen radical production stimu-
lated with opsonized zymosan was measured by luminol-amplified
chemiluminescence (CL) (mean SEM, peak CL in mV, ap < 0.02 vs.
A).
I mm 15 mm
0 A V A V
CU(N=4) 47±6 62±11 59 43± 10 20±5a
PAN (N = 1) 31 40 58 60 59
In spite of a similar decrease in circulating leukocytes on CU (V 1.2
0.2; A 1.0 0.2 x l09/liter), only cells collected from the venous site at
the maximum leukopenia were found to be significantly less responsive.
Conclusion: using CU, the down-regulation of neutrophils occurs only
transiently and within the dialyzer, suggesting that, besides systemic
complement activation, the membrane plays an additional role.
Vancomycin clearance in acute renal failure treated with hemoffi-
tration. G. Pot hoff, E. Horstmann, B. Könn, W. Klingler, Medizinische
Klinik der Ruhr, Universität Bochum im Knappschafts, Krankenhaus
In der Schornau 23-27, 4630 Bochum 7, West Germany. Vancomycin is
thought to be not removable by hemodialysis. A 43-year-old female
patient with septicemia, caused by staphylococcus aureus, developed
acute renal failure which was treated by continuous arteriovenous
hemofiltration (CAVH), and in addition intermittent pump-driven
ultrafiltration. Vancomycin (1 g i.v.) was given initially according to
directions; a further dose of 500 mg was to be given after 8 days. Daily
vancomycin serum levels, however, declined more rapidly than antic-
ipated, reaching subtherapeutic levels after 4 days. On the eighth day
the drug was no longer detectable in the serum. According to levels
determined in the ultrafiltrate, the elimination rate with pump driven
ultrafiltration was 237 mg per session and declined subsequently parallel
to declining serum levels (no further dose being given initially) to 156
mg. The calculated vancomycin clearance was 160 ml/min. On the other
hand the elimination rate with CAVH, corresponding to the lesser flow,
was comparatively small, being 29 mg/day. The clearance was calcu-
lated as 0.173 mI/mm. With adjusted dosage regime of vancomycin and
staphylococcus septicemia was controlled and the patient recovered.
Vancomycin has to be considered as a drug of primary importance in
the treatment of staphylococcus septicemia. The directions for treat-
ment of anuric patients with vancomycin are not valid with
hemoffitration and should be revised.
Results of therapeutic plasma exchange in Charité Hospital. K. Precht,
E. ROseler, B. Nieter, H. Miller, Humboldt Univ. Berlin, German
Democratic Republic, Klinik für Innere Medizin (Charite). In the past
ten years an increasing number of plasma exchanges (PB) were reported
in several, macromolecular substances mediated, diseases. Indications
of therapeutic PE up to now is widespread. Our report reflects the
clinical results in the past four years on Charité Hospital in Berlin,
GDR. We performed 370 membrane plasma separations in 71 patients
(pts). Plasmaflux 2 (Fresenius) was used. The exchanged plasma
volume was equivalent to about one and a half of the patient's plasma
volume. Indication groups were: neurological diseases 23%, nephrolog-
ical diseases 16%, rheumatic diseases 28%, hepatic disorders 16%,
hyperviscosity syndrome 7%, miscellaneous 10%. Before PE most of
our pts were not treated effectively with other conservative schedules.
PB was applied additionally in these emergency cases. The overall
success rate with high efficacy in our Pts was 48%, moderate in 18%,
doubtful in 9% and without any effect in 25%. The best results were
obtained in pts with neurological diseases (acute and chronic
polyneuroradiculitis type Guillain Barré and acute and chronic
myasthenia gravis) in 82% (N = 17) followed by hepatic disorders in
55% (N = 11) and rheumatic diseases (SLE and Renauds' syndrome) in
55% (N = 20). Clinical complications during PB were rare and easy.
They were noted in 14%. Therapeutic PE is a life saving method in
selected cases not responding to conventional immunosuppressive
therapy.
Quantifying treatment of short time, high flux hemodialysis. W.
Probst, J. Lattmann, U. Binswanger, Nephrologische Station,
Departement fur Innere Medizin, Universitatsspital, CH-8091 Zurich,
Switzerland. In view of shortened treatment time using high efficiency
filters for hemodialysis, the demand for quantitative assessment is
growing. The present work was undertaken to evaluate potential errors
applying the dialysis index K x T/V (K = clearance of the dialyzer, V
= volume of urea distribution, T = length of dialysis dialysate collec-
tion and serum urea measurement before and after treatment. Fourteen
stable patients treated during 2.5 to 3.5 hours three times weekly using
polysulfon capillary filters F60 were investigated. Results were as
follows (means sn).
Calculation mode K V
KxT
V
K : in vitro data1 V : 0.58 x body wt 225.36 25.15 34.34 4.56 1.05 0.15
K : in vivo data2 V : 0.58 x body 173.00 23.69 34.34 4.56 0.80 0.09
K : 1 invivodialysate
V : j' and blood urea 173.00 23.96a 38.88 9.34 0.73 0.l4a
Significance: I vs. 2, 1 vs. 3: P < 0.001
These data demonstrate lower K values for urea amounting an average
of 77% when estimated from in vivo as compared to in vitro data. The
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calculation of the dialysis index using individualized in vivo data is
lower. According to our experience, values <I seem not to be associ-
ated with higher patient morbidity, but careful further observation is
needed.
Corticosteroid induced stimulation of atrial natriuretlc peptide (ANP)
in man. H. Saxenhofer, M. Angst, P. Weidmann, S.G. Shaw, C.
Ferrier, Medizinische Poliklinik der Universiiat Bern, Switzerland.
Previously, we reported elevated plasma immunoreactive ANP (irANP)
levels from the 2nd to the 9th day of administering either prednisone, 50
mg/day, or 9a-fludrocortisone acetate (9aF), 0.6 mg/day, to normal
humans. To investigate the course of plasma irANP levels during the
first 48 hr of corticosteroid administration, 9 healthy men (mean age
5EM, 24 1 yr) received in randomized sequence: study A) a 4
hr-intravenous infusion of prednisolone sodium tetrahydrophthalate (50
mg bolus following 0.15 mg/mm as a constant infusion rate), followed by
oral administration of prednisone, 25 mg bid on the 1st study day and 25
mg tid on the 2nd study day; or study B) a 4 hr-infusion of aldosterone
(0.5 mg bolus followed by 0.15 tg/min as a constant infusion rate)
followed by the oral administration of 9aF, 0.6 mg on the 1st and 0.9mg
on the second study day. Basal supine plasma irANP levels averaged 32
5 pg/ml in study A and 30 6 pg/mI in study B; they were largely
unchanged up to 24 hr of prednisone or successive aldosterone and 9aF
administration, but rose (P <0.01) to 56 9 pg/mI and 62 12 pg/mI,
respectively, at 48 hr of the two interventions. During prednisone,
blood pressore (BP) and indices of the sodium-fluid volume state were
unchanged. During 9aF administration, body weight increased (-1- 1.1
0.3%, P < 0.001) while urinary sodium excretion (—63 7%, P <
0.001), hematocrit (—4.1 1.1%, P < 0,001) and plasma renin activity
(—38 4%, P < 0.001) decreased. Conclusions. The increase in
circulating irANP at 48 hr of administering either prednisone or 9aF
demonstrates a distinct but slow response of the ANP system to these
corticosteroids in normal humans. Since the glucocorticoid prednisone
does not acutely elevate BP or body sodium-fluid volume, it may stimulate
ANP release directly through cardiac glucocortieoid receptors. 9aF
may activate ANP release both indirectly through sodium-fluid volume
expansion and directly via nonspecific binding to glucocorticoid recep-
tors. ANP could play a potential role in mediating and/or modulating
physiological and pathophysiological effects of corticosteroids.
Long-term administration of calcium salts as alternative phosphate
binders. W. Schulz, H.J. Deuber, HI. Med. Klinik, Klinikum Bamberg,
Bamberg, Federal Republic of Germany. Aluminium is the most
important factor for the development of osteomalacia and encephalop-
athy in patients on maintenance hemodialysis. The aim of this study
was to investigate whether calcium carbonate, calcium gluconate or
calcium citrate can be used as alternative, aluminium-free phosphate
binders. Thirty-five patients, aged 20 to 80 years, were treated with
calcium carbonate, calcium gluconate or calcium citrate up to 3 years.
The aluminium containing phosphate binder was reduced stepwise. The
concentrations of calcium, sodium potassium, bicarbonate, and the pH
and the base excess were measured. The aluminium containing phos-
phate binder could be reduced from 3712 1457 mg/day to 2000 1100
mg/day (P < 0.05). The final doses of calcium carbonate, calcium
glueonate and calcium citrate were 2175 783 mg/day, 6825 1379
mg/day and 7747 2185 mg/day, respectively. During this treatment
phosphate was reduced from 8.2 1.5 mg/dl to 6.4 2.5 mg/dl.
Calcium raised slightly from 2.3 0.2 mmollliter to 2.4 0.1
mmol/liter. The acidosis was only reduced by calcium citrate from pH
7.24 to pH 7.31. Conclusion. Calcium carbonate as well as calcium
gluconate and calcium citrate can be used as alternative phosphate
binders; they effectively reduce phosphate levels and avoid aluminium
intoxieatioos because of the diminished dose of aluminium-containing
phosphate binders.
Treatment of nephrotlc syndrome with cyclosporin. A. W. Schulz, W.
Rebstock, A. Humpfner, Hf. Deuber, III. Med. Klinik, Klinikum
Bamberg, Bamberg, Federal Republic of Germany. There are very
good experiences in the treatment of transplantation patients with
cyclosporine A (CsA). Additionally, encouraging success is gained in
treatment of autoimmune diseases with CsA. The aim of this study was
to investigate the possibility of treating glomerulonephritis with ne-
phrotic syndrome with CsA. Fifteen patients, aged 35 17 years,
suffering of glomeruloncphritis with nephrotie syndrome from 37 47
months, were treated with CsA doses between 2 and 6 mg/kg daily
according to clinical necessities. They were diagnosed as having
idiopathic membraneous glomerulonephritis (N = 8), minimal change
glomerulonephritis (N = 3), membranoproliferative glomerulonephritis(N = 2), focal/segmental glomeruloselerosis (N = 1) and mesangiopro-
liferative glomerulonephritis (N = 1). During the treatment of 30 16
weeks the creatinine serum concentrations, the proteinuria, the blood
pressure, side effects and the dose of cortisone were documented every
second week. Proteinuria was lowered significantly (P < 0.05) from 8.9
3.5 g/day before treatment to 6.2 1.2 g/day during treatment, and to
6.9 2.3 g/day after treatment. The necessary cortisone doses could be
lowered significantly (P C 0.01) during CsA treatment from 12.8 11
mg/day to 3.5 1.8 mg/day. The serum creatinine concentrations after
CsA therapy (1.6 0.5 mg/dl) were significantly (P C 0.05) higher than
during therapy (1.2 0.1 mg/dl). The blood pressure did not show any
significant alteration during therapy with CsA. The reported side effects
were: fatigue (N = 5), anorexia (N = 3), diarrhea (N 2), depression(N = 2), gingival hyperplasia (N = 3), dizziness (N = 1), hypertrichosis(N = 4), tremor (N = 3). Preexisting edema ceased after several weeks
of CsA treatment. Conclusion. Using CsA doses of 2 to 6 mg/kg daily,
the nephrotic syndrome can effectively be treated without severe side
effects. Additionally, CsA therapy permits a significant reduction of
cortisone in the treatment of nephrotic syndrome.
Effects of the adenosine Al-receptor antagonist 8-cyclopentyl theophyl-
line in post-ischemic acute renal failure in the rat. S.G. Shaw, P.
Weidmann, A. Zimmermann, J. Hodler, Med. Poliklinik University of
Berne, Switzerland. Adenosine (AD) may be involved in the pathogen-
esis of ischemic acute renal failure (ARF) in the rat as tbeophylline
(TPL), a weak AD-receptor antagonist, protects against ARF. Howev-
er, the mechanism of protection or role of AD remains unclear since
TPL blocks both AD! and AD2 receptors and may also inhibit phos-
phodiesterase (PD). To clarify the role of receptor subtypes and PD,
renal effects of TPL before and after RAC were compared with
8-cyclopentyltheophylline (CPT), an analogue which permits selective
blockade of ADI receptors (low dose) or AD! +AD2 receptors (high
dose) without PD inhibition. Three groups of pentobarbital anaesthet-
ized, Sprague-Dawley rats were studied. One group received TPL (111
rtmol i.v and 66 jsmol/kg/hr i.v) 2 hr before inducing ARF by 45 mm of
left renal artery clamping (RAC); the non-RAC right kidney served as
control. Two other groups received CPT in low (6 jsmol/kg/hr i.v) or
high (120 jrmol s.c. and 20 jxmol/kg/hr i.v) doses according to the same
protocol. Inulin clearance (GFR), fractional sodium excretion
(FENa+), urine volume (Uv) and histology were assessed 2 hr after
RAC. TPL blocked peripheral AD2-receptor responses, did not affect
right kidney GFR, but reduced medullary hyperemia and increased
GFR in left kidneys, which had previously been isehemic, for 45 mm
(from 0.08 0.01 in control to 0.26 0.04 ml/min/lOO g, P C .001). In
normal kidneys low dose CPT increased Uv and FENa+ (0.5 0.06 to
2.9 0.22 mI/hr and 0.67 0.1 to 8.9 0.6 mE/minlloo g, respectively,
P < 0.001) without increasing GFR, but did not improve GFR or
histology after RAC. Higher doses, which blocked peripheral AD2-
receptor responses, improved GFR in RAC kidneys (from 0.05 0.01
in control to 0.22 0.02 ml/minlloo g, P C 0.001). As CPT is a selective
ADI antagonist at low doses and AD1 +AD2 antagonist at high doses
the results indicate: a) AD1 receptors may tonically influence FENa+
and Uv; b) PD-inhibition may not be part of the protective effect of
TPL; c) ADI-receptor blockade alone does not improve GFR after
RAC; d) the level of AD2-receptor blockade may partly determine the
degree of preservation of GFR after ischemia.
Epidemiologic study of analgesic ahuse in Switzerland. Overall and
urorenal mortality (1968—86). F. Stiirmer, U.C. Dubach, B. Rosner,
Med. Universitatspoliklinik, Petersgraben 4, 4031 Basel, Switzerland
Channing Laboratory, Harvard Medical School, Boston, Massachu-
setts, USA. In 1968 a study group of 623 working women 30 to 49 years
old with objective evidence of intake of phenacetin containing analge-
sics, and a matched control group of 621 women without such intake
were assessed. The cohort was controlled six times from 1969 to 1978
for laboratory evidence of urinary tract disorders. The study group did
not differ from the control group in development of bacteruria,
hematuria or proteinuria. However, a low specific gravity of urine after
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thirsting overnight and an elevated serum creatinine level were more
frequent in the study group. For purposes of mortality analyses the
study group was subdivided into a high-NAPAP and a low-NAPAP
subgroup according to the measured urinary N-acetyl-p-aminophenol
(NAPAP) concentration. The vital status of 85% of all women in the
original cohort could be ascertained through 1986 (19 years of fol-
low-up). Ninety-two deaths occurred by November 1986 (9%). The
cause of death and concomitant diseases were documented for 91
women in one or more of the following ways: whenever possible by
autopsy records (for 54%), by clinical reports from hospitals where
subjects had died (for 27%), or by letter from the attending physician or
death certificates alone (for 18%). Overall mortality of the study group
(67 women) was higher compared to the control group (25 women).
Women with urorenal disorders belonged almost exclusively to the
high-NAPAP subgroup (15 cases), whereas the low-NAPAP subgroup(I case) did not show a higher prevalence than the control group (3
cases). There were 30 malignomas in the total study group compared to
17 in the control group. Both cases of transitional cell carcinoma
occurred in the high-NAPAP subgroup and both cases of kidney
carcinoma in the control group.
Atrial natriuretic peptide in mild to moderate chronic renal failure. S.
Suda, P. Weidmann, H. Saxenhofer, C. Cottier, S.G. Shaw, C. Ferrier,
Med Poljklinjk, University of Bern, Switzerland. Plasma immunoreac-
tive atrial natriuretic peptide (irANP) levels and effects of synthetic
human aANP (ahANP) on blood pressure (BP), renal function (by
conventional clearance technique with bladder catheterization, using
PAH and SlCr-EDTA) and some endocrine variables were investigated
in 13 patients with mild to moderate chronic renal failure (mean age
SEM, 46 4 yr). Under basal conditions, plasma creatinine averaged 2.6
0.5 mg/dl and BP 166/107 7/2 mm Hg. Plasma irANP levels were
elevated compared with healthy humans of similar age (98 16 vs. 42
4 pg/mI, P < 0.001) and correlated (P < 0.005) positively with systolic
BP (r = +0.75) or fractional sodium excretion (r = +0.75). ahANP
infusion at successive rates of 0.034 and 0.077 tg/kg/min (each for 45
mm) produced exaggerated increases in irANP (> twofold compared
with normal subjects). The lower infusion rate augmented (P < 0.05 to
0.01) glomerular filtration rate (GFR, +22%), diuresis, and urinary
sodium, chloride, calcium, phosphate and magnesium excretion. Dur-
ing the high ahANP infusion rate, diuresis and electrolyte excretion
remained elevated (P < 0.05 to 0.01) despite return of GFR to control
values and decreasing renal plasma flow. ahANP infusion also de-
creased BP (P <0.05 to 0.01), produced hemoconcentration (hemato-
crit +7%, P < 0.01) without negative body fluid balance, and increased
(P < 0.01 to 0.001) plasma norepinephrine, insulin and serum-free fatty
acids; plasma aldosterone and renin activity were unaltered during but
rose after cessation of ahANP infusion. Conclusions. In mild to
moderate renal failure, circulating irANP increases and may possibly
support the homeostasis of sodium balance. Infused ahANP can
augment diuresis and electrolyte excretion through both increased GFR
and tubular mechanisms, produced hemoconcentration and BP reduc-
tion which occur in part independently of diuresis and are accompanied
by sympathetic activation, and stimulates plasma insulin.
Successful erythropoetin treatment of anemia impairs the efficiency of
hemodialysis. J. Vogtli, B. Stutz, M. Zbinden, U. Binswanger, Neph-
rologische Station, Departement für Innere Medizin, Universitäts-
spital, 8091 Zurich, Switzerland. Five chronic patients on hemo-
diafiltration (HDF) were successfully treated by recombinant human
erythropoetin (EP); (Cilag, Schaffhausen). HDF was performed thrice
weekly for 2-1/2 hours using polysulfon filters Fresenius F60 and
substituting 4.51 of ringer lactate 33.75 mmol/liter for prevention of
dialysate back flow. Protein catabolic rate (PCR) and target BUN level
(TAC) were calculated from serum BUN measurements, treatment time
and urea clearance of the filter. Results were as follows (mean SD):
EP
HKt
%
PCR
g/kd/day
TAC BUN
mg/dl
Before 22.7 2.4 1.6 0.2 50.8 28.1
After 34.7 2.7a 1.8 0.5 67.6 l5.2a
Paired t-test, before vs. after, P < 0.01
The data show an increase of Hkt and a significant iTAC of 15.6 4,6
mmol. At stable treatment conditions and an unchanged PCR, a
decrease in dialysis efficiency by about 30% is shown which is thought
to be due to a decrease of plasma circulation in the filter. This change
might imply prolongation of treatment time or change to a more efficient
filter.
132 Microglobulin: Serum levels and removal in hemodialysis (HD) and
continuous ambulatory peritoneal dialysis (CAPD) treated patients. U.
Binswanger, J. Vogtli, B. Stutz, Nephrologische Station, Departement
für Innere Medizin, Universitätsspital, 8091 Zurich, Switzerland. 132
microglobulin levels in serum and dialysate were estimated using a
radioimmunoassay kit (Pharmacia). HD patients underwent 3 treat-
ments for 2.5 to 3.5 hours weekly using a polysulfon capillary filter
(Fresenius F60). CAPD patients exchanged 7.5 to 10 liters daily.
Results are as follows (mean SD):
Serum concentrations
mg/liter
Removal
mg/day
HD
(N = 9) 22.00 8.22a 50.04 17.40
CAPD
(N = 13) 25.10 7.41 33.22 9.99
a Mean value of estimations before and after dialysis
Mean hemodialysis filter clearance was calculated from the amount of
132 microglobulin recovered in total dialysate divided by mean serum
concentration before and after treatment, and time of therapy was 30.5
3.0 mI/mm. The distribution volume estimated from the amount
removed, calculated as distribution volume limes concentration de-
crease, was 18.1 2.4% of body weight, closely reflecting extracellular
fluid space. /32 microglobulmn production rate as calculated in hemodi-
alysis patients from pre- and post-dialysis serum concentrations were
similar to the daily removal in CAPD patients under stable conditions.
Both dialysis procedures investigated remove similar amounts and
result in comparable /32 microglobulin serum levels.
Serum acetate concentrations after short time, high flux hemodialysis:
Relationship to hypotonic episodes. U. Binswanger, J. Vogtli, Nephro-
Iogische Station, Departement für Innere Medizin, Universitatsspital,
8091 Zurich, Switzerland. Serum acetate levels after hemodialysis
(Polysulfon capillary filter F60, dialysate acetate 35 mmol/liter, flow 500
mI/mm) were estimated in ultrafiltrate of serum samples by means of an
ezymatic kit (Boehringer-Mannheim). According to end dialysis serum
acetate concentrations, two groups of patients exhibiting more or less
than 5 mmol/liter of acetate were assigned. Treatment modalities and
patient data were as follows [low vs. high acetate, mean SD (range )].
Serum acetate in mmol/liter: 2.55 1.03 (1.09—4.76) vs. 7.65 2.48
(5.56—11.80); body weight, kg: 62.3 9.9 (47—89) vs. 57.5 14.7
(38—73); blood flow, mllmin; 243.1 43.9 (200—300) vs. 278.7 38.8
(200—300); treatment time, hr: 2.96 0.32 (2.5—3.5) vs. 2.67 0.26
(2.5—3.5); hypotonic episodes, pat./group: 4/13 vs. 2/6. Although ten-
dencies can be observed indicating that lower body weight, higher
blood flow and shorter treatment time are accompanied by higher end
dialysis acetate levels, the differences between groups were not signif-
icant. The frequency of hypotonic blood pressure episodes and the
degree of acetate accumulation was found to be loosely correlated and
therefore could not be used as a predictor of hemodynamic instability in
this group of patients, which did not include cases with liver disease.
Short time, high flux dialysis using acetate as the buffer is an acceptable
treatment mode for the majority of patients.
Calcium transfer during acetate (A) and bicarbonate (B) hemodialysis.
U. Binswanger, with the technical assistance of C. Cajet, E. Huber, H.
Kubista, Nephrologische Station, Departement für Innere Medizin,
Universitatsspital, 8091 Zurich, Switzerland. Dialysate buffer decreases
ionized calcium (Ca ) by complex formation. The present work was
initiated to evaluate differences of A and B in respect to patient total
calcium (CaT) uptake and change in serum calcium fractions. Three
patients were studied 3 times each during A and B hemodialysis using
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dialysis session, exhibiting short term depression by 6 to 10% and a
reduction of SO2 by 2% alternatively were observed in 3 patients;
instability of SO2 readings and changes up to 8% during the whole
treatment were observed in 4 patients. Short time disturbances oc-
coned when registered simultaneously on one finger of both hands.
_____________________________________________________________
Observations were not significantly influenced when using cuprophane
instead of polysulfon filters; during bicarbonate instead of acetate
dialysis; and by filtering the blood before the dialyzer. Pulse oxymetric
findings were verified by conventional blood 0, analysis. Small changes
of SO2 reflect much larger variations of P02, this relationship being
influenced further by 2, 3 DPO, Pa CO2 and pH. Our data indicate that
relative changes of oxygen supply occur during dialysis and can be
divided in long term effects and short term alterations. They might
contribute to incompatability of the dialysis treatment. The continuous
_____________________________________________________________
monitoring points to the difficulty of interpreting single measurements
during dialysis.
Kidney function after "customary" protein load: Clearance study and
microalbumin excretion rate. U. Binswanger, J. Hofmann, M.
Hugentobler, G. Keusch, J. Latt,nann, J. Peters, W. Probsi, U.
Widmer, Nephrologische Station, Departement fur Innere Medizin,
8091 Zurich, Switzerland, Dietary protein in high doses is known to
increase renal blood flow and glomerular filtration rate in normal man;
its role for progression of renal failure is suggestive. This study was
initiated in order to evaluate excretory kidney function and
microalbumin excretion rate after a "normal" protein load. Volunteers
were the nephrology crew listed above considered to represent a group
of people with normal kidney function. Serum and urine chemistry of a
2-hour sampling period was studied twice, starting 1 hour after a lunch
with salad and steak (200 g 40 g of protein) and 4 days later after a
"salad only" meal. Hydration included mineral water ad libitum.
Results were as follows (mean SD):
— Protein + Protein
Serum creatinine pinol/liter 89.52 10.75 94.63 13.74"
Urea excretion rate ,nmol/min 0.24 0.07 0.31 0.07a
Creatinine clearance mI/mm 95.16 18.16 108.92 26.72a
Albumin excretion rate mg/mm 0.02 0.02 0.03 0.0?'
vs i3 protein, "paired 1-test F < 0.05; b NS
There was a correlation between creatinine clearance and urea excre-
tion in urine (r = 0.72), but no relationship to salt excretion. These data
demonstrate a discrete significant increase of serum creatinine and
creatinine clearance after a usual protein meal reflecting most likely a
physiologic response. No acute increase in albumin excretion occurred,
which might have pointed towards functional damage. Whether repeat
or chronic protein loading leads to kidney damage without underlying
disease is a matter of debate.
Quantiflying dialysis treatment. W. Frobst, I. Lattmann, U. Bins-
wanger, Nephrologische Station, Departement fur Innere Medizin,
Universitatsspital, CH-8091 Zurich, Switzerland. In view of shortened
treatment time using high efficiency filters for hemodialysis, the demand
for quantitative assessment is growing. The present work undertaken to
evaluate potential errors applying the dialysis index K x T/V (K
clearance of the dialyzcr, V = volume of urea distribution, T = length
of dialysis treatment), when estimating clearance from in vitro data or
from in vivo dialysate collection and V from the body weight (V 0.58
x body wt) or from urea content of the sampled dialysate and the
change of systemic urea concentration in the blood of the patient during
the treatment. Results: N = 14.
K x Ta
Calculation mode K" V V
K : in vitro data 225.36 25.15V : 0.58 x body wt
K : in vivo data 173.00 23.69V 0.58 x body wt
K 1 in vivo dialysate 173.00 23.96V : J and blood urea
"P < 0.001
polysulfon capillary filters F60. Dialysate composition was: A: CaT 1.75
mmol/liter, acetate 38 mmol/liter; B: CaT 1.75 mmol/liter, bicarbonate
32 mmol/liter, acetate 3 mmol/liter. Results (mean SD):
Dialysate A B Significance
Ca" 1.50 0.01 1.42 0.03 P C 0.05
Gradient (CaTdjalysate
Before dialysis
After dialysis
Calcium uptake
mmol/liter
Blood Ca (afterCat
>Ca + + blood; mmol/liter)
0.44 0.13 0.55 0.10
0.20 0.08 0.33 0.03
9.20 1.74 3.57 4.73
dialysis), mmol/liter
1.71 0.06 1.57 0.01
NS
P C 0.05
NS
P C 0.05
Main results include a lower Ca + in B dialysate, a higher gradient at
the end of B treatment, no significant difference in Ca uptake due to
large variation during B treatment, and a significantly higher Ca after
A dialysis. Correlation studies between gradient and calcium uptake per
100 ml of blood passing the filter showed higher transfer of calcium
during A and B treatment at gradients <0.5 mmollliter. It is concluded
that A and B hemodialysis with the same total dialysate calcium content
results in lower end treatment Ca + blood concentrations which might
predispose to secondary hyperparathyroidism. The amount of calcium
uptake during both modes of hemodialysis treatment is small.
Oxaiate removal during high flux hemodialysis (HD) and continuous
ambulatory peritoneal dialysis (CAPD) treatment. U. Binswanger, J.
VOgtli, B. Stutz, Nephrologische Station, Departement fur Innere
Medizmn, Universitdtsspital, 8091 Zurich, Switzerland. Oxalate reten-
tion was found by others to occur in renal insufficiency and to be of
importance by its deposition in many organs. We studied serum oxalate
levels and removal by HD (Polysulfon capillary filter F60) and CAPD
(10 liters exchange/per day) by estimating oxalate in ultrafiltrates of
serum or dialysates using a modified colorimetric method according to
Hodgkinson. Results were as follows (mean SD):
Serum level Removal
Patients mmol/liter mmol/day
0.134 0.045 1.47 0.51
0.93 0.25"
HD
(N = 16)
CAPD 0.118 0.019
(N = 14)
"F11 vs. CAPD, P C 0.001
Serum oxalate levels before HD and during CAPD were similar for the
two treatment modes investigated, inspite of higher removal rate during
HD treatment. Whether different buffers (acetate vs. lactate) are
involved has to be investigated. Serum concentrations studied in 4 HD
patients on and off vitamin C supplements during unchanged dialysis
treatment were 0.171 0.050 and 0.083 0.029 mmol/liter, respec-
tively, indicating restricted use of vitamin C for supplementation to be
appropriate.
Continuous pulse oxymeter studies during hemodialysis treatment. 1'.
Gilli, U. Binswanger, Nephrologische Station, Departement fur Innere
Medizin, Universitdtsspital, 8091 Zurich, Switzerland. Continuous
pulse oxymetry for estimations of oxygen saturation were performed in
38 patients dialyzed 3 times a week during 2.5 to 4 hours using
polysulfon capillary filters (P60). The whole group showed a significant
depression of SO2 by 1.9% of the base line value. Seven patients studied
repeatedly (more than 3 studies) exhibited a significant mean decrease
of SO2 from 1.5 to 4.2%, mostly occurring during the first 60 minutes of
treatment. Short term depression of SO2 occurred by 6 to 9% during
sleep, speech, coughing or vomiting. The evaluation of severe blood
pressure drop was not possible due to lack of measuring signal at
peripheral sites. Short term changes of SO2 without clinical signs
included: temporary drop of SO2 during 1 minute by 3 to 22% in 3
patients; abrupt or slowly developing depression of SO2 by 3 to 6% and
establishment of a new lower level during 20 to 60 minutes in 3 patients;
episodes of 20 to 60 minutes duration occurring in the second half of the
34.34 4.56 1.05 0.15
34.34 4,56 0.80 0.09
38.88 9.34 0.73 0.14
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These data demonstrate lower K values estimated from in vivo data and
increased distribution of volume for urea. The in vivo clearance of the
dialyzer is only 77% of the in vitro clearance. The calculation of the
dialysis index from in vitro data is overestimated. According to the
experience, values <1 seem not to be associated with higher patient
morbidity, but careful further observation is needed.
Akanthocytes in glomerular hematuria—A typical urinary erythrocyte
deformity. E. Wandel, M. Marx, W. Mayet, M. Weber, H. KOhIer, I.
Med. Klinik, Universitát Mainz, Federal Republic of Germany. A high
percentage of different shaped erythrocytes in urine sediments is a
characteristic sign of glomerular hematuria, due to the findings of Birch
and Fairley. The aim of our study was to investigate the dysmorphy of
urinary erythrocytes by a qualitative analysis which could be helpful in
the diagnosis of glomerular bleeding. We examined 573 urine samples of
patients with a hematuria by phase-contrast microscopy. A sediment
was only tested when a hematuria with more than 8000 erythrocytes/ml
was found. Exogenous factors such as variations in pH, osmolality and
the so-called cover glass effect could induce morphologic changes in the
urinary erythrocytes which were classified as glomerular erythrocytes
by the findings of Birch and Fairley. Only typically deformed red cells
with extrusions, the so called akanthocytes, could not be produced by
exogenous factors and were only seen in glomerular hematuria. A water
diuresis reduced all urinary cell types related to dilution. The amount of
akanthocytes was not changed. This fact is contradictory to the
development of these shapes along the tubular passage. Our study
shows that akanthocytes represent a typical urinary red cell deformity
which cannot be produced by exogenous factors. This qualitative
urinary analysis of red cells can be used for the diagnosis of glomerular
hematuria.
Four years experience of low-dose cyclosporine therapy after renal
transplantation. J.P. Wauters, M. Burnier, J.C. Stauffer, M. Campiche
and R. Mosimann, Division de Nephrologie, Service de Chirurgie B et
Institut de Pathologie, CHUV, Lausanne, Switzerland. Since August
1983, 100 patients receiving a renal transplant in our unit were treated
by a low-dose cyclosporine (CsA) regimen in order to avoid nephrotox-
icity. CsA was given at the dose of 5 mg/kg/day intravenously, then 7
mg/kg/day by mouth and then adapted to attain trough CsA blood levels
between 100 and 400 ng/ml. Prednisone was associated at the dose of
0.7 mg/kg/day, progressively reduced and usually stopped 7 months
after grafting. Mean age was 42 years (18 to 68), 48 patients were
considered at risk: age above 50, second graft, diabetes, Wegener or
lupus. Actuarial graft survival was 91% at 1 year and 85% at 2 years.
The most frequently observed side-effect of CsA was hirsutism. At all
times after renal transplantation, mean serum creatinine levels were
comparable in the CsA and our previous conventional therapy groups.
In those patients treated for at least 1 year, the reciprocal of serum
creatinine remained stable at 0.7 throughout the observation period.
Among 50 kidney graft biopsies, no lesions of CsA toxicity were
observed up to 30 months after grafting. Conclusion. Provided a
low-dose regimen is used, CsA does not appear to induce long-term
nephrotoxicity while the beneficial effect of CsA on graft survival is
maintained.
Hypertensive dysregulation and its modification by calcium channel
blockade in chronic non-oliguric renal failure. P. Weidmann, D. Schohn,
M.P. Gnädinger, E. Biirgisser, C. Ferrier, H. Jahn, Med. Poliklinik,
University of Bern, Switzerland, and Servieg de Nephrologie,
Université Louis Pasteur, Strasbourg, France. To investigate the
pathogenetic constellation and its modification by calcium channel
blockade in hypertension associated with chronic non-oliguric renal
failure, blood pressure (BP), various pressor factors or correlates,
cardiovascular responsiveness, and plasma atrial natriuretic peptide
(ANP) were assessed in 15 hypertensive patients (serum creatinine, 1.8
to 8.1 mg/dl) before and after 6 weeks of intervention with the agent
nitrendipine. Results were compared with basal values in age-matched
healthy humans. On placebo, the hypertensive renal patients had
significantly higher values of supine plasma angiotensin II (Ang II)
aldosterone, norepinephrine (NE) and heart rate (HR), lower responses
of BP to Ang II or NE and of HR to isoproterenol, and a lower plasma
Ang II clearance than healthy humans (P < 0.05 to 0.001). Plasma ANP
(by radioreceptor assay) was significantly elevated, correlated with
systolic BP (r = +0.59), decreased upon standing or furosemide
injection, and rose in response to NE pressor infusion (P < 0.05 to
0.001). Exchangeable sodium and blood volume did not differ signifi-
cantly from normal values. Nitrendipine reduced the cardiovascular
responses to Ang II, NE and isoproterenol, lowered supine BP from
173/102 5/2 to 146/81 3/3 mm Hg and upright BP from 170/105 5/2
to 145/86 4/3 mm Hg (P < 0.05 to 0.001); except for a slightly
increased plasma Ang II, levels of other endocrine variables, exchange-
able sodium, blood volume, and creatinine clearance were not signifi-
cantly modified. Conclusions. Hypertension accompanying chronic
nonoliguric renal failure seems to be strongly Ang II- and probably also
NE-dependent. A diminished plasma Ang II clearance can promote
hyperangiotensinemia. Activation of the ANP-system may possibly
contribute to sodium homeostasis. Calcium channel blockade with
nitrendipine interferes with cardiovascular Ang II- and NE-dependence
and may be useful for first-line antihypertensive pharmacotherapy in
renal failure.
OKT3 treatment of steroid- and/or ATG-resistant renal altograft
rejection occurring on triple baseline immunosuppression including
cyclosporine A. U. Widmer, D. Frei, G. Keusch, H.R. Burger, F.
Largiadèr, U. Binswanger, Departement für Innere Medizin, Chirurgie
und Institut für Pathologie, Universitatsspital, CH-8091 Zurich, Swit-
zerland. The monoclonal antibody Orthoclone OKT3 was used for
rescue treatment of steroid- and/or ATG-resistant rejection episodes in
9 cadaver donor renal allograft recipients on triple maintenance therapy
including cyclosporine (mean level 260 ng/ml before OKT3). The group
was considered immunologically highly risk: 5 patients had had a prior
transplant, 3 had a previous rejection episode in the current transplant,
mean number of HLA-B and DR mismatches was 1.7 (range 0 to 3), 8
patients had panel-reactive antibodies (PRA) and 2 of them were highly
immunized with PRA> 50%, 2 patients were juvenile onset diabetics.
Diagnosis of rejection was confirmed by percutaneous graft biopsy in all
patients. First line treatment consisted of methyiprednisolone pulses
during 3 to 5 days, 7 out of 9 patients received additionally aS to 14 day
course of ATG Fresenius 3 mg/kg/day. Five mg of OKT3 were given for
6 to 14 days (mean 10 days). Total peripheral blood lymphocyte counts
decreased after the first dose of OKT3 to a mean of 85/zi (range 0 to
270/j.d). No HSV or CMV infections were observed. Reversal of
rejection occurred in all patients between days 2 and 6. After follow-up
of 4 to 8 months, serum creatinine levels were <260 mol/liter in 3
patients, <400 mol/liter in 3 patients, >400 jLmol/liter in 2 patients,
and 1 patient returned to dialysis 9.3 months after transplantation.
Judged by linear regression analysis using the reciprocal value of serum
creatinine versus time, 5 patients had stable and 3 patients had
increasing serum creatinine levels. We conclude that OKT3 is effective
and safe for rescue treatment in immunologically high-risk CD trans-
plant recipients, and might have a stabilizing effect on long-term graft
function without evidence of rebound or recurrent rejections.
Sclerosing peritonitis as late complication of CAPD. K. Záruba, A.
Schaffner, H. Jungbluth, Nierenstation, Stadtspital Waid, Zurich,
Switzerland. In the early eighties peritoneal fibrosis has been recog-
nized as a serious complication of peritoneal dialysis. It is characterized
by the deposition of a thick layer of fibrous tissue on the peritoneum.
The clinical consequence is a reduction or even loss of ultrafiltration
capacity. In the advanced stage there is a thickening and shrinkage of
the mesenterium and a cocoon-like encapsulation of bowel loops with
the sclerotic connective tissue. The so-called sclerosing encapsulating
peritonitis is associated with a high morbidity and mortality. We have
seen this complication in one of our 100 patients who have been treated
with CAPD since 1979. After 31 months on CAPD he changed to home
hemodialysis because of recurrent bacterial peritonitis. Two and one-
half years later he developed symptoms of partial small bowel obstruc-
tion. The laparatomy revealed a severe sclerosing encapsulated perito-
nitis. After the adhesiolysis with bowel mobilization the patient
recovered. Since then he is on home hemodialysis for two years again
despite a recurrent enterocutaneous fistula. In the prevention of this
serious complication it is essential to eliminate all the possible risk
factors irritating the peritoneum, such as acetate dialysate, peritonitis,
contamination of dialysate with bacterial toxins from inline bacterial
filters, or with plasticizers from the dialysate bag-system and with
antiseptics, as well as the osmotic irritation with hypertonic dialysate.
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Apart from this, we started a program for the early detection of
peritoneal fibrosis: We assess regularly the peritoneal function in
measuring the ultrafiltration capacity in all our CAPD patients. Also, in
case of a laparatomy, a peritoneal biopsy is done.
Substitution of phosphate binders containing aluminIum by calcium
carbonate and magnesium carbonate in patients on maintenance dialysis.
U. Zellweger, P.1. Zaugg, A. Many, Dialysestation, Medizinische
Klinik, Kantonsspital, CM-MOO Winterthur, Switzerland. Aluminium
has been shown to be the major contributor to the dialysis encephalop-
athy sytidrome and an osteomalacic component of renal osteoçiystro-
phy. To evaluate the efficacy and side effects of calcium carbonate and
magnesium carbonate as a alternative phosphate binder, we studied 20
patients with ëhronic renal failure undergoing hospital hemodialysis (11
men 9 women, mean age 50.5 years, with renal replacement therapy for
35 months, range ito 135 months). During the contro! period (1 month),
the patients continued to take the previously prescribed amount of
phosphate linders that contain aluminium (Aluminiumhydroxid',
Alueol', antiphosphateR, mean dose 4.1 g/day Al(OH)3, range 2.25 to
7.2): During the intervention period (3 months), the patients were
switched to the aluminium-free antacid (Rennie', 1 tablet with 680 mg
CaCO3 and 80 mg MgCO3; mean dose 6,6 g/day CàCO3, range 4.1 to
10.2, ançi 0.8 g/day MgCO3, range 0.5 to 1.2). The meati serum
aluminium decreased after 2 months from 3.0 to 1.5 smol/liter (P C
0.001). The thean serum calcium increased from 2.2 to 2.4 nigiol/liter
among patients with recurrent episodes of hypercalcemia. Six of 20
patients dveloped mild hypercalcemia in the first 3 months of inter-
vention; the lower calcium bath retained the serum calcium in normal
range. The mean serum phosphate decreased from 1.85 Q.4to 1.45
0.4 thmol/liter; furthermore there was a slight increase of serum
bicarbonate from 18 2 to 21 3 mmol/liter. The mean serum
parathyroid hormone (PTH-NH2) decreased from 1.2 to 0.8 ng/ml after
3 moriths of intervention, but remained upper the normal tage (n C
0.25 ng/ml). There was no change in sodium, potassium, magnesium
and alkaline phophatnse values. Conclusion. With the used aluminium-
free antacid, there is a remarkable reduction of the aluminium load and
a good control of hyperphosphatemia obtainable in patients with chronic
renal failure undergoing hemodialysis. A reduction in the concentration of
calcium in the dialysate will help to control hypercalcemia.
Human recombinant erythropoietin (EPO) treatment In transfusion
dependent anensic patients (PTS) on maintenance hemodialysis (lID). C.
Zehnder, A. Blumberg, Medizinische Klinik, Kantonsspital Aarau,
Switzerland. Six anemic RD patients dependent on regular blood
transfusions, 1.8 0.7 (mean sn) units red cells/month, and with
massive iron overload were treated with EPO. The initial dOse of 300
lU/kg/week (wk) was increased in steps of 75 JU/kg/wk every 3 wIt until
a hemoglobin (Hb) of 10 g/dl was reached. The effect on Hb, absolute
reticulocyte count (RC) and serum ferritin were studied during a 20 wk
period. Mean red cell life span (normal value 115 days) and red cell
volume were measured with 51Cr-sodium chromate at baseline and after
20 wk of EPO. RC and Hb rose markedly without any further need for
transfusions, red cell volumes increased concom(tantly, while serum
fenitin decreased slowly (Table). Mean red cell life spnn was shortened
and remained unaltered during EPO treatment. All data are means SD.
Time Hb Reticulocyte
weeks g/dl counts/mm3
0 6.8 Q,3 55,600 31,200a
4 9.8 l. 174,900 3l,000a
12 11.2 1.3 93,600 25,100
20 10.3 0.8 120,800 56,400
Red cell volume
% of normal
Ferritin
j.tg/liter
Red cell life span,
days
5g 4
81 II
3,550 l,615z
2,937 l,554C
3,199 1,717
2,721 1,506
45 18.1
47 4.1
U P C 0.001; b Pc 0.005; C P C 0.05, .1 NS
Conclusions. EPO is very effective in treating the anemia of
polytransfused patients on RD. The favorable effects of EPO on fib
concentrations and red cell volumes occurs in spite of persistent
hemolysis with consistently shortened red cell life spans. The increase
in erythropoiesis together with the elimination of transfusions lead to a
slow reduction in iron overload.
Effect of theophylline in experimental hypercapnic renal Insufficiency.
E. Zihlmann, f-B. Oouyon and J.-P. Guignard, Unite de Néphrologie,
Service de Pédiatrie, CHUV, loll Lausanne, Switzerland. Normocap-
nic hypoxemia and normoxemic hypercapnia both induce an increase in
renal vascular resistance (RVR) with consequent renal hypoperfusion in
the newborn rabbit. The hypoxemia-induced vasoconstriction can be
prevented by infusing the animal with low-dose theophylline. The
potential beneficial renal effect of theophylline in hypercapnic acidosis
was investigated in 24 anesthetized and mechanically-ventilated rabbits
aged 5 to 12 days. Each animal acted as its own control. Normoxemic
hypercapnia (PaCO2 = 75 mm Hg) induced an increase in urine flow
rate, a sharp decrease in inulin clearance (GER), from 2.2 0.1 to 1.5
0.2 mI/kg mm, and PAH clearance from 9.6 0.9 to 4.7 0.8
mi/kg mm, and a significant increase in filtration fraction. In 8 rabbits,
amihophylline (2 mg/kg) was administered at the onset of the
hypercapnic period (PaCO2 = 75 mm Hg) which followed a control
normoxemic period. In these conditions, acute hypercapnia was asso-
ciated with an increase in urine flow rate, no change in GFR, a decrease
in PAH clearance from 9.0 0.6 to 5.9 0.6 mI/kg mm, and a
significant increase in filtration fraction, The beneficial effect of
theophylline on glomerular function during hypercapnic acidosis could
be ascribed to its inotropic systemic effect and/or its ndenosine antag-
onistic properties.
Vascular complications and catheter survival in temporary subclavian
vein access for hemodlalysis. M.C. Hugentobler, G. Keusch, P.C.
Baumann, U. Binswanger, Medizinische Klinik, Departement für In-
nere Medizin, Universitatsspital, 8091 Zurich, Switzerland. Alarmed by
some severe complications recently observed in temporary vascular
access for hemodialysis by subclavian vein catheters, we reviewed our
cases at risk for complications due to this procedure from January 1984
to September 1987 (45 months). Out of a total of 163 consecutive
patients we included 77 in our retrospective study. For each case
survival time of the catheter in situ relative to right or left side
subclavian vein access was analyzed. We found a significantly higher
catheter survival in right side (N = 46) than in left side (N = 31)
subciavian vein access: right side 15.2 3.9 day (range 2 to 47 days);
left side 11,2 3.3 day (range 3 to 30 days); P <0,001. InS of the 77
patients (6.5%) we observed serious complications. Three of them
developed clinical signs of a subclavian vein thrombosis 7, 13 and 24
days after catheter insertion. One of these patients died of pulmonary
embolism at day 21 after catheter insertion; a second lethal pulmonary
embolism occurred in a patient 9 days after catheter insertion, The third
patient was lost after severe mediastinal and pulmonary hemorrhage
due to perforation of the left brachiocephalic vein with penetration of
the hemodialysis catheter into the right upper lobe of the lung; the
catheter was inserted 9 days before. We conclude that the choice of the
right subclavinn vein for temporary vascular access for hemodialysis
results in a significantly higher catheter survival rate compared with the
left side. Major and minor complications limit the acceptance of the
subclavian vascular access; it should be restricted to situations of high
emergency,
Antithymocyte globulin (ATG) treatment of steroid-resistant rejection
In patients receiving immunosuppressive triple therapy, L. Widmer, G.
Keusch, D. Frei, HR. Burger, U. Binswanger, Nephrologische Station,
UniversiEatsspital, 8091 Zurich, Switzerland. Rejection remains the
major cause of graft loss in cadaver kidney transplant recipients. In
order to evaluate the efficacy and the complication rate of ATG
treitment of steroid-resistant rejection episodes (RE) in patients receiv-
ing immunosuppressive triple therapy with prednisone, azathioprine
and cyclosporine, we analyzed 51 episodes of biopsy proved, steroid-
resistant acute rejection in 49 patients (pts), Forty-one pts received
their first cadnveric renal transplant. ATG (Fresenius Company) was
given in a dose of 3 mg/kg body weight during 11 3 days. ATG dose
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was decreased if there was a fall in the platelet count. Thirty-nine pts
received 41 ATG courses within 6 months post-transplant and 10 pts
were treated after 6 months, respectively. Triple immunosuppressive
therapy was continued during ATG administration. Thirty-six biopsy
specimens showed 25 cellular rejections and 11 vascular rejections,
respectively. In the remainder 4 specimens a mixed pattern was found.
Despite the initial treatment with 4.6 1.2 x 1 g i.v. prednisolone,
serum creatinine increased in all cases by 93 105% (range 4 to 538%).
At one year follow-up after ATG treatment, 36 of 49 pts had functional
allografts, renal function being normal in 22 pts. In 9 pts serum
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creatinine stabilized at an 82 53% elevated level in comparison to
pretreatment value and in 5 pts creatinine increased from 198 30 to
411 202 mo1/liter, respectively. Graft survival at one year after ATG
treatment was 79% in pts treated within 6 months post-transplant and
50% in pts treated after 6 months, respectively. The following side
effects during ATG-treatment were observed: Serum-sickness (2 pts);
anaphylactic shock (1 pt); viral infections (3 pts). Conclusions. ATG-
treatment was highly efficacious of reversing steroid-resistant RE
especially within 6 months post-transplant in pts receiving triple im-
munosuppressive therapy without a high risk of severe infection.
